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Summary 
von Hippel-Lindau (VHL) disease is an autosomal-dominant monogenetic disorder caused by 
inheritance of mutations of the VHL gene. Amongst other clinical manifestations, VHL 
patients have an increased risk of developing renal cysts and bilateral multifocal solid or 
cystic clear cell renal cell carcinomas (ccRCC). ccRCC in VHL patients is believed to arise 
from cystic precursor lesions in some cases and independently of cysts in other cases. The 
VHL gene is also biallelically inactivated in up to 90% of sporadic ccRCC cases, 
approximately 5% of which are multilocular cystic renal cell carcinomas. This suggests that 
sporadic ccRCC may also form through cyst-dependent as well as cyst-independent 
pathways. The protein product of the VHL gene (pVHL) is involved in many molecular 
processes, including HIFα regulation and stabilization of the microtubule network. The latter 
function seems to be particularly important for the cyst-dependent progression model due to 
the role of pVHL in regulating the stability of the primary cilium, a specialized microtubule 
structure that functions as a cellular antenna. Genetic mutations that compromise the 
structure or signalling functions of the primary cilium cause diverse types of polycystic kidney 
diseases, indicating that the primary cilium is an organelle that suppresses the formation of 
renal cysts. This thesis tested the cooperative effects of loss of Vhl function and loss of the 
primary cilium in mouse kidneys, to attempt to model the initial cellular changes that occur in 
the development of ccRCC. 
 
We first developed a µCT imaging approach and validated this technique as a suitable tool to 
quantitatively monitor cyst formation and progression longitudinally and non-invasively in vivo 
in mice. This technique will likely be generally beneficial for all future studies of polycystic 
kidney diseases in rodent models. We show that renal epithelial-specific co-deletion of Vhl 
together with Kif3a, a key component of the primary cilium, shortens the latency of cyst 
initiation and enhances cyst formation and size. In addition, combined deletion of Kif3a and 
Vhl resulted in an ~4 fold increase in the formation of atypical cysts compared to Kif3a 
deletion alone. These lesions appear similar to the lesions that are proposed to be the 
precursor lesions of ccRCC in humans. One possible mechanism that may account for the 
increased formation of simple cysts and increased rate of progression to atypical cysts is an 
increased frequency of non-planar cellular divisions in Vhl/Kif3a double mutant mice. These 
studies give rise to a new model of initiation of ccRCC whereby loss of the primary cilium 
represents a secondary event in VHL mutant cells that cooperates with additional cellular 
changes that arise due to loss of pVHL function to induce simple and atypical cyst formation. 
It appears that additional genetic alterations are necessary to allow neoplastic transformation 
and progression of these precursor lesions to cystic or solid ccRCC. 
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A second aim of this thesis was to investigate the hypothesis that HIF1α may play a general 
role in cyst formation in the kidney, based on observations that HIF1α is stabilized in cystic 
epithelial cells due to microenvironmental hypoxia. Recent studies proposed that HIF1α 
activation functions to promote cyst formation. In contrast to these studies, we found that 
cystic lesions induced by Kif3a deletion are not characterized by HIF1α stabilization. 
Moreover, deletion of Hif1a in the Kif3a knockout model of cyst formation did not alter the 
timing of initiation or extent of growth of cysts, nor did it affect the frequency of atypical cysts. 
It appears that HIF1α stabilization in renal cysts may be limited to more severe cystic 
phenotypes or that additional cellular signaling changes induced by mutations of the 
PKD1/PKD2 genes in autosomal dominant polycystic kidney disease may contribute to 
HIF1α activation. Our genetic studies in a physiologically relevant model of polycystic kidney 
disease clearly indicate that HIF1α stabilization does not modify cystic phenotypes. 
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Zusammenfassung 
Die von Hippel-Lindau (VHL) Erkrankung ist eine autosomal dominante Erbkrankheit, welche 
durch Mutationen des VHL Gens verursacht wird. Neben anderen klinischen 
Erscheinungsformen haben VHL Patienten ein erhöhtes Risiko beidseitig Nierenzysten und 
multilokuläre solide oder zystische klarzellige Nierenzellkarzinome (NZK) zu entwickeln. Es 
wird angenommen, dass NZK in VHL Patienten in einigen Fällen aus zystischen 
Vorläuferläsionen und in anderen Fällen unabhängig von Zysten entstehen. Das VHL Gen ist 
außerdem in bis zu 90% der sporadischen NZK Fälle biallelisch inaktiviert, ungefähr 5% 
davon sind multilokulär zystische Nierenzellkarzinome. Dies deutet daraufhin, dass 
sporadische NZK wahrscheinlich zysten-abhängig, wie auch –unabhängig, entstehen. Das 
Proteinprodukt des VHL Gens (pVHL) ist in viele molekulare Prozesse involviert, unter 
anderem auch in die HIFα Regulierung und die Stabilisierung des Mikrotubulinnetzwerkes. 
Die letztere Funktion scheint besonders wichtig für das zysten-abhängige Entstehungsmodell 
zu sein, da pVHL eine Rolle in der Regulierung der Stabilität der primären Zilie, eine 
spezialisierte Mikrotubulistruktur, welches als zelluläre Antenne funktioniert, spielt. 
Genetische Mutationen, welche die Struktur oder die Signalfunktionen der primären Zilie 
stören, führen zu diversen Arten von polyzystischen Nierenerkrankungen. Dies deutet 
daraufhin, dass die primäre Zilie ein Organell ist, welches die Entstehung von Nierenzysten 
unterdrücken kann. Diese Doktorarbeit untersucht den kooperativen Effekt des Verlustes der 
Vhl Genfunktion und des Verlustes der primären Zilie in Maus Nieren, um ein Modell für die 
initialen zellulären Veränderung, welche während der Entwicklung von NZK entstehen, zu 
entwickeln. 
 
Zuerst haben wir einen Ansatz für bildgebende µCT Daten entwickelt und diese Technik zur 
quantitativen Überwachung von Zystenbildungen und –entwicklung als geeignetes Mittel zur 
wiederholten nicht invasiven in vivo Methode in der Maus validiert. Diese Technik wird 
generell für alle zukünftigen Studien von polyzystischen Nierenerkrankungen in kleinen 
Nagern nützlich sein. Wir zeigen, dass nierenepithelspezifische zeitgleiche Deletion von Vhl 
und Kif3a, einer wichtigen Komponente der primären Zilie, die Latenzzeit des Zystenbeginns 
verkürzt und die Zystenentstehung, sowie die Zystengröße, erhöht. Zusätzlich führt die 
gleichzeitige Deletion von Vhl und Kif3a zu einer ~4 fachen Erhöhung der Entstehung von 
atypischen Zysten im Vergleich zur Einzeldeletion von Kif3a. Diese Läsionen scheinen 
ähnlich zu den Läsionen zu sein, welche als Vorläuferläsionen für NZK im Menschen gelten. 
Ein möglicher Mechanismus, der die erhöhte Entstehung von einfachen Zysten und die 
erhöhte Rate zum Übergang in atypische Zysten erklären kann, ist die erhöhte Frequenz von 
nicht-planaren Zellteilungen in Vhl/Kif3a doppelmutanten Mäusen. Diese Studien zeigen ein 
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neues Modell der Initiierung von NZK auf, wobei der Verlust der primären Zilie ein 
sekundäres Ereignis in VHL mutierten Zellen ist, welches mit weiteren zellulären 
Veränderungen kooperiert, die durch den Verlust der pVHL Funktion entstehen und zu 
einfachen, sowie atypischen Zysten führen. Es scheint, als wären weitere genetische 
Veränderungen nötig, um neoplastische Transformation und die Entwicklung von 
Vorläuferläsionen in zystische oder solide NZK zu erzeugen. 
 
Ein zweites Ziel dieser Doktorarbeit war es die Hypothese, dass HIF1α eine eher generelle 
Rolle in der Zystenentstehung in der Nieren spielen soll, zu untersuchen. Diese Hypothese 
beruht auf Beobachtungen, dass HIF1α in zystischen Epithelzellen durch Hypoxie stabilisiert 
ist. Jüngste Studien schlagen vor, dass HIF1α Aktivität die Entstehung von Zysten fördert. Im 
Gegensatz zu diesen Studien haben unsere zystischen Läsionen, induziert durch Kif3a 
Deletion, keine HIF1α Stabilisierung gezeigt. Zusätzlich unterschieden sich die Mäuse mit 
Deletion von Hif1a im Kif3a knockout Modell für Zystenentstehung weder im Zeitpunkt der 
Zystenentstehung, dem Ausmaß des Wachstums noch in der Frequenz von atypischen 
Zysten. Es scheint, als wäre HIF1α Stabilisierung in Nierenzysten auf schwerere zystische 
Phänotypen beschränkt oder dass zusätzliche zelluläre Mechanismen, wie z.B. durch 
Mutationen in PKD1/PKD2 Genen, verantwortlich für autosomal dominante polyzystische 
Nierenerkrankung, die Stabilisierung von HIF1α unterstützen. Unsere genetischen Studien in 
einem physiologisch relevanten Model für polyzystische Nierenerkrankungen zeigen deutlich, 
dass die Stabilisierung von HIF1α den zystischen Phänotyp nicht beeinflusst. 
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Abbreviations 
ADPKD Autosomal-dominant polycystic kidney disease 
AE1 Anion exchanger 1 
Aqp2 Aquaporin 2 
ATPV1B1 ATPase H+ transporting lysosomal V1 subunit B1 
ARPKD Autosomal-recessive polycystic kidney disease 
BSA Bovine serum albumin 
µCT micro Computed Tomography 
DABCO 1,4-diazabicyclo[2.2.2]octane 
DBA Dolichos Biflorus Agglutinin 
DICOM medical imaging file format 
DMEM Dulbecco´s modified Eagle’s medium 
DTT Dithiothreitol 
EDTA Ethylenediamine tetra acetic acid 
EGF epidermal growth factor 
FCS fetal calf serum 
H&E haematoxylin and eosin 
HBSS Hank´s balanced salt solution 
HC hydrocortisone 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HGF hepatocyte growth factor 
HIF hypoxia-inducible factor 
i.v. intravenously 
IF immunofluorescence 
IFT intraflagellar transport 
LTA Lotus tetragonolobus agglutinin  
NaN3 sodium azide 
NaPi Sodium/phosphate cotransporter 
NCC sodium-chloride symporter 
NKCC2 Na-K-Cl cotransporter 2 
PAGE polyacrylamide gel electrophorese 
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PBS phosphate buffered saline 
PCP planar cell polarity 
Pen/Strep Penicillin/Streptamycin 
PGE1 prostaglandin 1 
PKD Polycystic kidney disease 
PMSF Phenylmethanesufonyl fluoride 
RIPA Radioimmunoprecipitation assay protein lysis buffer 
SBA sodium boric acid 
SDS sodium dodecyl sulfate 
SRB Sulforhodamine B sodium salt 
SS sodium selenite 
T3 Triiodothyronine 
TBS Tris buffered saline 
TEMED N,N,N´,N´-Tetramethylethylenediamine 
TF transferrin 
THP Tamm-Horsfall protein 
VHL von Hippel-Lindau 
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1 Introduction 
1.1 VHL disease  
Von Hippel-Lindau (VHL) disease is an autosomal dominant inherited genetic condition with 
an incidence of 1:36,000 live births (1, 2). VHL patients have an increased risk of developing 
benign and malignant tumours, including haemangioblastomas, renal cysts, renal 
carcinomas and phaeochromocytoma (3). VHL disease is caused by germline mutations 
(deletions, missense or splicing defects) of the VHL tumour suppressor gene located on 
chromosome 3p25 (4, 5). In addition to hereditary VHL disease, the VHL gene is inactivated 
in up to 90% of sporadic cases of clear cell renal cell carcinoma (ccRCC) (6-11). 
Approximately two-thirds of patients with VHL disease develop renal cysts and clear cell 
renal cell carcinoma (ccRCC) (3, 12, 13). VHL disease can be split into two distinct clinical 
phenotypes based on the risk of patients for phaeochromocytoma (14-16). Type 1 VHL 
disease exhibits low risk of phaeochromocytoma whereas type 2 VHL disease is 
characterized by a high risk of developing phaeochromocytoma. Both of these subtypes can 
be further divided by their mutation status and their risk of RCC. Type 1A disease is 
characterized by a high risk of RCC and truncating mutations or missense mutations that 
impair pVHL (the VHL gene product) folding whereas type 1B shows a low risk for RCC and 
large deletions of the VHL gene. Type 2 can be divided into three groups, all of which are 
caused by missense mutations. The risk of developing RCC is low in Type 2A, high in Type 
2B and extremely low in Type 2C patients (14-16). Mutations of the VHL gene are distributed 
over all three exons (9).  
Several models of deletion of the mouse VHL homologue, Vhl, have been generated. The 
germline deletion of Vhl resulted in embryonic lethality due to dysfunctional placental 
vasculature (17). Mosaic deletion of Vhl (β-actin-Cre) resulted in hepatic vascular tumours 
and increased angiogenesis in the kidney (18). Specific Vhl inactivation in the proximal 
tubule cells (Pepck-Cre) resulted in the development of a small number of renal cysts in 
about 20% of mice after one year of age (19). Furthermore, deletion of Vhl in all nephron 
segments (Pax8-Cre), all segments but the proximal tubules (Ksp1.3-Cre) or the thick 
ascending limb only (Thp-Cre) did not lead to ccRCC formation (20-23). Thus, Vhl deletion 
alone in renal epithelial cells does not cause proliferative dysregulation or the formation of 
ccRCC. Recently, combined deletion of Vhl and Pten in renal epithelia was shown to cause 
polycystic kidneys and the combined deletion of Vhl and Trp53 in the kidney resulted in cyst 
formation and also the induction of neoplasms, mimicking apparent precursor lesions of 
ccRCC but not causing ccRCC (see section 1.1.4) (20, 24). These studies collectively show 
that Vhl inactivation alone is not sufficient to induce ccRCC formation in the mouse and that 
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additional mutations most likely need to occur to induce malignant transformation. This 
project aims to investigate using mouse genetics the initial events that occur in the formation 
of ccRCC precursor lesions and also seeks to contribute to the longer term goal of 
generating the first autochthonous mouse model of ccRCC. 
 
Figure 1.1: Regulation of HIFα by pVHL. (A) In normoxia, HIF-αs are hydroxylated by the PHD enzymes. pVHL forms an E3 ubiquitin 
ligase complex that binds the α-subunits of the HIF-α protein and marks them with ubiquitin. This results in the proteasomal degradation 
of the HIF-α. (B) Under hypoxic conditions, HIF-α are not hydroxylated by the PHD enzymes therefore escaping pVHL dependent 
degradation. In addition, mutations of the VHL gene that prevent the binding of HIF-α or the association with the other E3 ubiquitin ligase 
complex members lead also to the accumulation of HIF-α. This accumulation results in gene expression of HIF-α target genes. E3 = 
members of the E3 ubiquitin ligase complex; HIF-α = hypoxia-inducible factors α; PHD = prolyl hydroxylases; VHL = von Hippel-Lindau 
tumour suppressor. 
1.1.1 VHL gene product (pVHL) 
The VHL gene was first isolated in 1993 (4). Two gene products are transcribed from the 
VHL gene locus due to an internal translation start at codon 54. This results in two proteins 
with an apparent molecular weight of 30kDa and 19kDa, respectively (25-28). The term 
pVHL refers to both VHL gene products. pVHL consists of two major structural domains: an 
N-terminal β-domain and a smaller C-terminal α-domain (29). The β-domain contains mainly 
β-sheets whereas the α-domain spans the amino acids 155 to 192 and comprises α-helices. 
The most studied function of pVHL is its role as the substrate-binding subunit of an E3 
ubiquitin ligase complex that targets substrates for proteasomal degradation. In addition to 
pVHL, the complex consists of elongin C, elongin B, Cullin 2 and Rbx1 (10, 29-33). Under 
normoxic conditions this ubiquitin ligase complex binds to the α-subunits of the hypoxia-
inducible factors (HIF1α, HIF2α and HIF3α) and marks them for ubiquitination and 
proteasomal degradation. The mechanism of this will be discussed in section 1.1.2. In 
addition, there is evidence that pVHL is also involved in regulating other cellular processes, 
VHL
pVHL E3
HIF-α
Normoxia
degradation
VHL 
(mutated)
pVHL E3
HIF-α
accumulation
& gene expression
A B
PHDUb
PHD
Hypoxia / Vhl mutations
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including microtubule stability (34). pVHL´s influence on microtubules and therefore on the 
function of the primary cilium and will be addressed in section 1.3.  
1.1.2 Regulation of HIFα by pVHL 
The hypoxia-inducible transcription factors (HIFs) consist of three HIFα members (HIF1-3α) 
and HIF1β which is also called ARNT (aryl hydrocarbon receptor nuclear translocator) (33, 
35, 36). HIFα and ß contain the same domains including a basic helix-loop-helix domain for 
DNA binding, a PAS domain for dimerization and a C-terminal transactivation domain 
(CTAD) for the interaction with other proteins. In normoxia, the HIFα subunits are rapidly 
degraded through interaction with prolyl hydroxylases (PHDs) and the pVHL/E3 ubiquitin 
ligase complex. The newly synthetized HIFα´s are hydroxylated at two conserved proline 
residues through one of the four mammalian PHDs (35, 37, 38). Only after hydroxylation at 
these proline residues are the HIFα´s recognized by the pVHL/E3 ubiquitin complex and 
targeted for degradation by direct interaction of the proline hydroxylated region of HIFα with 
the HIFα oxygen-dependent degradation domain (ODD) of pVHL. In normoxia and mild 
hypoxia, factor-inhibiting HIF (FIH) is able to hydroxylate an asparaginyl residue within the 
CTAD and thereby inhibits HIF transactivation activity by altering protein-protein interactions 
with the co-activators p300 and CREB-binding protein (CBP) (39). Under hypoxia, the 
unhydroxlated HIFα cannot be bound by pVHL and therefore accumulates in the cell. The 
HIFα´s translocate into the nucleus and form heterodimers with the constitutively expressed 
HIF1β. The HIFα/HIFβ complex recruits p300 and CBP and binds to nuclear DNA, so called 
hypoxia response elements (HREs) (40). Binding of HIF complexes to HREs increases gene 
expression involved in but not limited to cell proliferation, survival, angiogenesis and energy 
metabolism (Glut1). To date more than 70 different genes have been shown to be directly 
regulated by HIF (41). Inactivation or functional loss of pVHL results in the accumulation of 
HIFα and in HIFα target gene expression. In addition, HIF1α accumulation was detected in 
large cysts of rodent PKD (polycystic kidney disease) models due to the presence of hypoxic 
regions in these cystic kidneys (42). There is conflicting data concerning whether HIF1α has 
a direct influence on cyst formation or not. One study showed that deletion of HIF1α leads to 
decreased cyst formation in in vitro cyst formation models and that HIF1α overexpression 
leads to increased chemical induced cyst formation in vivo (43). On the other hand, data from 
a genetic model involving Vhl deletion showed that deletion of Hif1a does not suppress 
formation of cysts in vivo (19). One aim of this project is to investigate whether HIF1α is 
activated in cysts that form due to the absence of the primary cilium (due to Kif3a deletion) 
and whether co-deletion of Hif1a affects cyst formation or progression in vivo. 
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1.1.3 PI3K/mTOR pathway in cancer 
The phostatidylinositol-3-kinase (PI3K) and the mammalian target of rapamycin (mTOR) 
signaling pathways regulate cell growth and cell survival in physiological and 
pathophysiological conditions. Mutations in either of these pathways enable cell growth that 
is unrestricted by extracellular cues and ultimately drive tumourigenesis through enhanced 
protein synthesis, cell cycle progression and changes in metabolism (44, 45). Activating 
mutations of receptor tyrosine kinases and PI3K subunits or inactivating mutations of 
negative regulators like PTEN are found in up to 30% of human tumours including breast and 
colon cancer but also kidney cancer (45). Cowden´s disease is a dominant inherited cancer 
syndrome with germline mutations in PTEN and a high percentage of sporadic cancers 
displays with PTEN mutations (46, 47). The activation of PI3K leads to the generation of 
phosphatidylinositol 3,4,5 triphosphate (PtdIns(3,4,5)P3) that activate the AKT1, AKT2, and 
AKT3 kinases (48, 49). AKTs are able to inactivate pro-apoptotic factors, negatively regulate 
TP53 through MDM2 activation, cause mTOR activation and inhibit GSK3β which regulates 
cell cycle progression, metabolism and is a part of the primary cilium maintaining network 
(see chapter 1.3) (48, 50, 51). mTOR forms dimers and participates in large protein 
complexes. In humans, two mTOR complexes (mTORC1 and mTORC2) with distinct 
functions are known. mTORC1 is activated in about 60-85% of ccRCCs (52, 53). mTORC1 is 
a key component of the cell´s metabolic and growth regulatory signalling networks (54-56). It 
is able to promote protein synthesis by phosphorylation and activation of S6 kinase and 
phosphorylation and inactivation of 4E-BP1 (57, 58). Regulation of mTORC1 is achieved by 
negative inhibition of Rheb through the tuberous sclerosis complex 1 (TSC1) and 2 (TSC2) 
tumour suppressor proteins (55). In turn, one pathway that regulates TSC2 is PI3K signaling. 
Given the frequency of activation of the PI3K/mTOR pathway in ccRCC, it appears likely that 
this may act cooperatively with pVHL loss to cause ccRCC (see section 1.1.4). 
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Figure 1.2: PI3K-mTOR pathway: Activation of the PI3K pathway through growth factors 
results in the activation of AKT. Active AKT is able to directly inhibit GSK3β, indirectly inhibit 
p53 and activates mTOR. This results in enhanced proliferation, cell growth, it influences the 
cell cycle progression and has an effect on the maintenance of the primary cilium. 
1.1.4 clear cell Renal Cell Carcinoma (ccRCC) 
The term RCC describes the set of cancers that arise from the renal tubular epithelia. There 
are 3 main histopathological entities. ccRCC accounts for ~65-80% of all reported cases 
followed by papillary RCC (~15-20%) and chromophobe RCC (5%) (59). Histological 
characteristics of ccRCC include glycogen and lipid-rich clear cells and a network of small 
blood vessels (60). On computed tomography (CT) images, ccRCC presents as typically 
hypervascular and heterogeneous lesions due to central necrosis, hemorrhage and/or 
calcification (Figure 1.1) (61). In addition to solid ccRCC several other subtypes are 
described. Some ccRCC display a cystic appearance with ccRCC tumour cells growing along 
the wall of the cyst within the cystic space and also growing as small clusters between cysts. 
These cases with no solid ccRCC and only cystic appearance are termed multilocular cystic 
RCC and account for 5% of all ccRCC (62). Some pVHL-deficient cysts that arise in patients 
with VHL disease also contain micro-foci of ccRCC. It appears that, at least in some cases, 
cystic regions represent a precursor lesion of malignant familial and sporadic cases of 
ccRCC (63, 64). The presence of renal cysts, the cystic appearances and the solid entities in 
many sporadic ccRCC suggest a not mutually exclusive concept of cyst-dependent and cyst-
independent progression models of ccRCC formation. This progression model is described in 
more detail in Figure 1.2 (65, 66). This thesis aims to test the hypothesis that cysts represent 
precursor lesions of ccRCC using a mouse genetic approach.  
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Figure 1.3: CT image of a ccRCC patient. Contrast-enhanced CT images show a large right renal mass with features typical of ccRCC, 
including central necrosis (asterisk) and peripheral heterogeneously hyperenhancing tissue (arrowheads). Axial (A, B) and coronal (C). 
Nephrectomy was performed and histopathology showed ccRCC, grade IV. Image from Krajewski et al. (67). 
 
 
Figure 1.4: Current model of ccRCC development and progression. Homozygous loss of VHL occurs frequently in VHL patients but 
only a small proportion of these VHL null cells progress into micro-cysts and the majority of VHL mutant cells appear to remain as single 
cells or as small clusters of cells. Micro-cysts are characterized by upregulated PI3K signalling and loss of the primary cilium. Cyst 
expansion leads to the enlargement of micro-cysts into larger simple cysts that are lined by a single epithelial layer. It is believed that 
some simple cysts can progress to form atypical cysts, which are characterized by regions of disorganized and multilayered epithelial 
growth, potentially reflecting a loss of epithelial planar cell polarity (PCP). It is likely additional pro-proliferative mutations, such as TP53 
mutations, are needed for the development of cystic ccRCC and probably further mutations may turn cystic ccRCC into solid ccRCC. 
This may occur through neoplastic growth completely filling the former cystic lumen. Little is known about the mechanisms by which VHL 
null cells may progress to form micro-ccRCC lesions with a solid appearance which may then directly go on to form solid ccRCC. In 
summary, it is believed that ccRCCs can form via cyst-dependent and cyst-independent precursor lesions. 
 
Bi-allelic loss of VHL, either through mutations, deletions, methylation or chromosomal 
loss, appears in most hereditary and sporadic cases of ccRCC. A recent study estimates the 
frequency of VHL loss in ccRCC to be up to 91% of cases (9). Very recently, The Cancer 
Genome Atlas consortium characterized ccRCC on a genome-wide molecular level (68). The 
analysis of over 400 tumours revealed that in addition to VHL mutations, ccRCCs frequently 
harbor activating mutations in the PI3K/mTOR pathway, mutations that impair normal cell 
cycle regulation (TP53, RB1, CDKN2A, MYC) as well as mutations in several genes involved 
in epigenetic regulation (PBRM1, SETD2 and BAP1). Thus, since these mutations occur in 
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different combinations in ccRCC, it appears that there are numerous different molecular 
subtypes of these tumours, which are described in more detail below. 
Dysfunctional pVHL prevents the degradation of HIF1α and HIF2α leading to their 
constitutive overexpression. Genetic data suggests that HIFα activation is an oncogenic 
driving force in ccRCC (69-71). However, several studies indicate that HIF1α and HIF2α 
carry out different roles in ccRCC development. Comparing Vhl-wild type and Vhl-deficient 
mouse tumor xenografts suggests that loss of pVhl function causes a growth disadvantage 
(72, 73). This effect may in part be based on the activation of HIF1α which exerts a growth 
disadvantage in MEFs in vitro and in human ccRCC xenografts (70, 74). This is likely to be at 
least partly mediated by opposing the cell cycle promoting activity of MYC through direct 
binding, transcriptional regulation of a MYC inhibitor (MXI-1) and promotion of MYC 
degradation (74, 75). HIF2α, in contrast, promotes MYC activity and promotes proliferation in 
MEFs and ccRCC xenografts (69-71, 75). In regard to cell cycle properties in ccRCC, HIF1α 
seems to inhibit tumour proliferation whereas HIF2α promotes tumour proliferation. ccRCC 
expressing both HIF1α and HIF2α display reduced MYC activity and are less proliferative 
than ccRCCs expressing HIF2α only (76). Several factors may contribute to this imbalance of 
HIF1α to HIF2α expression. ccRCCs frequently present with single copy loss of the HIF1A 
gene locus and ccRCC cell lines often harbor biallelic inactivation of the HIF1A locus (77, 
78). The hypoxia-associated factor (HAF) selectively targets HIF1α for proteasomal 
degradation and rather enhances HIF2α´s gene transactivation ability (79, 80). In various in 
vitro studies the expression of HIF1α and HIF2α seem to be mutually exclusive (70, 81). In 
addition, there is a differentially dependency of HIF1α and HIF2α on PI3K/mTOR activity 
which is frequently upregulated in ccRCC cases (82). In summary, it appears that HIF1α acts 
like a tumour suppressor, whereas HIF2α acts as an oncogene in established ccRCC 
tumours. However, the involvement of these proteins in tumour initiation has yet to be 
established. 
The PI3K pathway is upregulated in malignant and pre-malignant regions in the kidney 
of VHL patients (20). Mutations throughout the whole PI3K/mTOR pathway leading to 
activation of mTORC1 occur in ~28% of analyzed ccRCCs (68). Supporting the idea that 
cooperative effects of loss of pVHL function and activation of the PI3K pathway may 
contribute to ccRCC, the generation of a mouse with renal epithelial-specific combined 
deletion of Vhl and Pten caused a strong cystic kidney phenotype (20). Loss of primary cilium 
due to the diminished microtubule stabilization by Vhl deletion and inactivation of GSK3ß 
was proposed to contribute to the development of this cystic phenotype (see also chapter 
1.3) (51). Interestingly, these Vhl/Pten-deficient animals also developed multiple begin 
malignancies in the genital tract due to activity of the Cre driver in the embryonic structures 
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that gives rise to these tissues, further emphasizing the cooperative functions of the VHL and 
PTEN-controlled pathways in tumour formation (20).  
ccRCC can also be viewed as one of the so-called ciliopathies, diseases that are 
associated with dysfunction of the primary cilium (83). VHL disease, like the collection of 
polycystic kidney diseases (PKD), presents with renal cysts. ccRCC associated with loss of 
VHL shows a reduced frequency of cilia compared to papillary RCC (84). The primary cilium 
is linked to many different signaling pathways and cell polarity (83, 85, 86). The relationship 
between pVHL and the primary cilium will be addressed in section 1.3. 
Until now, the cell type or types that gives rise to ccRCC remains unclear. There is 
evidence that ccRCC is most often of proximal tubule origin. This idea is supported by the 
observation that many ccRCC cases exhibit positive immunoreactivity for proximal tubule 
specific antigens, including CD10, villin, renal cell carcinoma antigen, ICAM-1, MRP2 and 
lotus teraglonobulus agglutinin (87-92). Nevertheless, some cases of ccRCC express 
proteins specific for the distal tubule, including Cytokeratin 19, CD24 and α3-integrin (89, 91). 
Galectin-3 is also expressed in some ccRCC and is usually expressed in distal tubules and 
the collecting duct (93). These studies collectively show that ccRCC can express a broad 
variety of markers of different tubular segments, implying that these tumours can arise from 
different nephron segments. The implication of these observations for attempts to model 
ccRCC in mice is that gene deletion should be targeted to as many different nephron 
segments as possible. For this reason, we have employed the Ksp1.3-CreERT2 transgene 
(94), which induces gene deletion specifically in renal epithelial cells of all nephron 
segments. Since deletion of Vhl alone did not result in ccRCC formation in mouse models 
additional mutations or cellular changes such as those described above are likely to be 
required to enable Vhl-null renal epithelial cells to progress to cyst formation and ultimately 
ccRCC. In this thesis we focus on combined deletion of Vhl and abrogation of the primary 
cilium whose loss is known to induce kidney cysts.  
1.2 The primary cilium 
Once neglected by researchers, the primary cilium has become an intensively studied 
organelle over the past decade. The primary cilium is a microtubule-based organelle present 
on the vast majority of vertebrate cells (95). There are two types of cilia protruding from the 
cell, the motile cilia and the generally non-motile cilia (the primary cilium). Motile cilia are 
composed of 9 microtubule doublets surrounding a central doublet. This structure is known 
as 9+2 conformation. In contrast, primary cilia lack the central doublet, leading to a 9+0 
structure (96). Each cell expresses only a single primary cilium, which originates from the 
older (mother centriole) of the two centrioles in quiescent cells. Disassembly of the primary 
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cilium takes place as the cell re-enters the cell cycle (97). Assembly of the primary cilium 
follows a well-orchestrated formation of different steps (98, 99). First, the basal body 
migrates to the cell´s plasma membrane and connects to the actin filament and to cytosolic 
microtubules. During this process the basal body interacts with membrane vesicles that fuse 
to the membrane to form the ciliary membrane compartment. Secondly, an outgrowth of 
basal body microtubules protrudes beneath the ciliary membrane to give rise to the cilium. 
The starting point of this outgrowth is called the transition zone. Microtubule assembly is 
achieved from the distal tip of the cilium only (100). Even when the cilium reaches its final 
length this structure is highly dynamic. New tubulin is continually incorporated at the distal 
part but due to a steady turnover of the tubulin fibre the cilium does not continue to elongate 
(101-103).  
The construction of the primary cilium requires a process called intraflagellar transport 
(IFT). Because all ciliary proteins are synthesized in the cytoplasm, IFT complexes shuttle all 
proteins into the cilium and back to the cytoplasm if needed (reviewed in (104)). The transfer 
of IFT complexes with their cargo proteins to the tip of cilium is called anterograde transport 
and is mediated by the heterotrimeric kinesin II motor complex (Kif3a, Kif3b and Kap3). After 
the IFT complex reaches the tip it undergoes a transition resulting in inactivation of the 
kinesin and the retrograde transport is carried out by dynein (105-108). In this study we have 
utilized genetic deletion of Kif3a to cause genetic ablation of primary cilia. Further analysis of 
the IFT complexes showed that two subgroups are present, complex A (550kDa) and 
complex B (710kDa) (109). Mutations affecting IFT complex A (retrograde transport) result in 
shortened cilia with accumulation of IFT particles similar to dynein mutants whereas 
mutations in IFT complex B (anterograde) exhibit truncated cilia without IFT particle 
accumulation phenocopying kinesin mutations (101, 107, 110, 111).  
Research of the last decade placed the primary cilium at the center of several 
important signaling pathways (see chapter 1.2.1) and elucidated its role as a sensory 
organelle (104, 112). This was achieved by linking different genetic diseases to ciliary 
dysfunctions, the so-called ciliopathies (113). These ciliopathies include genetic syndromes 
like Alström syndrome, Bardet-Biedl syndrome (BBS), Joubert syndrome and Meckel-Gruber 
syndrome (reviewed in (114-116)). It was shown that the primary cilium is important for 
several sensory functions in the vertebrate animal. It functions as a mechanosensor on renal 
epithelial cells and it responds to fluid flow by an intracellular calcium signal (117). 
Dysfunction of IFT is detrimental for the outer segment of photoreceptors and photoreceptor 
defects are common in many ciliopathies (95, 118, 119). In addition, it was shown that 
odorant detection is impaired in BBS patients and in mouse cilia mutants (120). 
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1.2.1 Signaling from the primary cilium and planar cell polarity (PCP) 
The primary cilium is involved in a wide variety of signaling cascades including receptor 
tyrosine kinases, Hedgehog (Hh) and Wnt signaling (112, 121-124). 
Hh signaling is involved in developmental processes including growth patterning, cell 
fate determination, cell proliferation and cell survival (125). In addition, dysregulation of Hh 
signaling has been described to be involved in several tumor types including 
medulloblastoma, breast carcinoma, basal cell carcinoma and many more (126). Many 
publications link Hh signaling to the primary cilium. This relationship was initially discovered 
when a mouse mutant of Ift88 showed phenotypic manifestations of dysfunctional Hh 
signaling including altered digit number and loss of left-right asymmetry (127, 128). It could 
be shown that the Smo receptor is translocated to the cilium upon Hh binding and that the 
cilium is required for Smo activity (129, 130). Moreover, Gli1-3 and Sufu also reside in the 
distal tip and IFT proteins are needed to transmit activator and repressor functions of the Gli 
proteins into the cell (127, 128, 130, 131). Loss of Gli activator and repressor functions give 
rise to similar phenotypes to those observed in IFT mutant mice (128). 
There is evidence that the primary cilium has an influence on both canonical and non-
canonical Wnt signaling and vice versa (132). ß-catenin is associated with adherens 
junctions at the cell membrane in differentiated cells and is also present freely in the 
cytoplasm. Stabilization of ß-catenin through mutations or inactivation of APC leads to 
colorectal cancer (133). Transgenic mice overexpressing ß-catenin develop renal cysts 
(134). The non-canonical Wnt pathway regulates a pathway called  planar cell polarity (PCP) 
which dictates the cell´s cell division angle and the orientation of the mitotic spindle (135). In 
the kidney epithelium, tubular flow is sensed by the primary cilium, thus leading to an 
upregulation of Inversin. Inversin in turn targets Dishevelled (Dsh) for destruction and forces 
the cell to follow the non-canonical Wnt pathway to prevent cell divisions that are out of the 
division plane (136). Mutations in Inversin also lead to the development of a ciliopathy called 
nephronophthisis (137).  
Taken together, this data implicates a functional connection between Wnt signaling, 
the primary cilium and control of orientation of cellular division. Indeed, correct mitotic 
orientation of cells along the tubule axis is crucial for lengthening of renal tubules and it has 
been shown that in several rodent PKD models there is an increased frequency of pre-cystic 
epithelial cells that divide with incorrect mitotic orientation (138). Consistent with this finding, 
a colocalization of Vangl2 and BBS proteins at the basal body was reported (139) leading to 
the conclusion that the kidney cysts of BBS patients may be caused by misoriented spindle 
formation due to dysregulated Vangl2 (135, 138). In addition, other ciliary proteins including 
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Kif3a or Ift20 have also been shown to modulate Wnt signalling (140, 141). Kif3a or Ift20 
mutant pups display a severe polycystic phenotype that is preceeded by misorientation of 
cell division (94, 141). Interestingly, the rapid cystic onset seen after deletion of ciliary 
proteins during embryogenesis is lost if deletion occurs in quiescent adult kidney cells 
implying that a certain rate of proliferation, which is still present until P10 or can be induced 
through kidney damage, is needed for rapid cyst formation (94, 142, 143). Thus, it is believed 
that a major initiating step in cyst formation is the misorientation of cell division, resulting in 
initial tubular expansion. Another mechanism of how mitotic spindle orientation is regulated 
involves pVHL. Depletion of pVHL causes spindle misorientation in vitro by decreasing the 
stability of astral microtubules which function to couple the mitotic spindle to integrin contacts 
at the cell surface, thereby providing orientation to mitotic cell division (34, 66, 144). 
Recently, it was shown that Vhl-deficient mouse kidneys subjected to ischemic damage to 
induce epithelial proliferation exhibit spindle misorientation and form cysts and ccRCC 
precursor lesions (145). 
Hence, the loss of the primary cilium may contribute to cyst formation and the initial 
steps of malignant transformation through alterations in cell proliferation and cell survival (Hh 
signaling) and loss of polarization and mitotic spindle misorientation (PCP).  
1.2.2 Renal ciliopathies 
The umbrella name “ciliopathies” is used for a group of disorders associated with genetic 
mutations which result in malformation or dysfunction of the primary cilium. The first 
recognized ciliopathy was Bardet-Biedl syndrome (BBS). The first functional evidence of the 
involvement of the primary cilium came from the observation that BBS8, the protein product 
of one of the 14 genes that have been identified as being causal to the BBS syndrome, 
localizes to cilia and was linked to ciliogenesis and intraflagellar transport. The generation of 
BBS8 null mutants resulted in the classic situs invertus phenotype of cilia deficiency that is 
also observed in BBS patients (146). Additional analysis confirmed the localization of BBS8 
to the centrosomes and the basal body. Several human syndromes are grouped under the 
term ciliopathies, in these syndromes manifestations can occur in any organ but 
predominantly affect kidney, liver, eye and brain. Several renal diseases have been 
described in the context of different ciliopathy syndromes and can be classified i.e. into 
polycystic (PKD), renal medullary cystic disease (NPHP) and cystic dysplastic kidneys 
(Meckel-Gruber).  
Polycystic kidney disease (PKD) is a family of monogenic disorders with 
manifestations of multiple cysts primarily in the kidney and the liver (147). The disease is 
inherited either autosomal dominantly (ADPKD) or in a recessive (ARPKD) fashion. In 
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general, ADPKD is diagnosed in individuals of 20 to 40 years of age, while ARPKD leads to 
enlarged kidneys in utero or in the neonatal phase. While ARPKD is a rather rare disease 
with an incidence of 1:20,000, ADPKD is the most common genetically inherited cystic 
kidney disease, affecting between 1:400 and 1:1000 individuals (Figure 1.3B). ADPKD is 
caused by a mutation in either PKD1 or PKD2. These genes code for polycystin-1 (PC-1) 
and polycystein-2 (PC2), respectively. The majority of patients have mutations in PKD1 
(85%) whereas PKD2 is affected in only 15% of the cases (148, 149). PC1 and PC2 form a 
complex that is partly localized to the membrane of the primary cilium (150). PKHD1 
(polycystic kidney and hepatic disease 1) encodes for fibrocystin, a protein that also localizes 
to the cilium and interacts with the polycystin complex. Mutations in the PKHD1 gene cause 
ARPKD (Figure 1.3A).  
Nephronophthisis (NPHP) is a recessive cystic kidney disorder and the most frequent 
genetic cause for end-stage renal failure in children and young adults (Figure 1.3C). NPHP is 
a genetically very heterogeneous disease with at least 13 different identified genes. 
Surprisingly, these genes account for only 30% of the diagnosed NPHP cases (151). It was 
shown that the NPHP proteins 1-4 are able to form a complex with each other and that this 
complex localizes to the transition zone of the primary cilium (137, 152). 
Ciliopathies associated with cystic dysplastic kidneys (CDKs) include Meckel-Gruber 
syndrome (153). CDKs are characterized by poorly differentiated and disorganized nephron 
segments and a hypoplastic or malformed collecting system (154). CDKs still contain some 
normal nephrons. In contrast, multicystic dysplastic kidneys (MCDKs) are non-functional and 
the kidney is composed of cartilage and mesenchymal mantles surrounding undeveloped 
tubules (154). MCDK can be caused by heterozygous mutation of HNF1B, a transcription 
factor involved in the regulation of PKHD1 (155). PKHD1 (fibrocystin) is associated with the 
basal body and the primary cilium and mutations lead to ARPKD (156). 
In summary, the identification of the genes that underlie the above-mentioned cystic 
kidney syndromes led to the realization that all of the protein products of these genes are in 
some way linked to ciliogenesis or signaling pathways originating from the primary cilium and 
the dysregulation of these proteins by gene mutation impairs proper cilia function. The 
primary cilium is therefore a functional suppressor of kidney cyst formation. 
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Figure 1.3: Kidneys of different ciliopathy patients. (A) ARPKD kidney of an infant patient. (B) ADPKD kidney of an adult patient. (C) 
Kidney of a Nephronophtisthis patient. Images (A)+(B) are from Bisceglia et al. (157), (C) is from Hildebrant et al. (158). Adapted from 
Gunay-Aygun (159). 
1.2.3 Mouse models for renal ciliopathies 
In 1994, one of the first observations that cilia are linked to cystic kidney disease came from 
the Oak ridge polycystic kidney mouse (110, 160). In the following years, more and more 
mouse models resembling human cystic kidney disease were identified and generated. 
Some of the most important mouse models are described below. 
PKD1: A global homozygous deletion of Pkd1 is embryonically lethal with observed 
defects in kidney formation, pancreas and other organs (161, 162). Two different approaches 
were used to overcome this problem and generate a useful mouse model. On the one hand, 
the conditional deletion of Pkd1 after postnatal day 13 leads to a milder progression of the 
disease (163). On the other hand, a kidney specific deletion of Pkd1 was achieved by 
creating a Ksp-Cre;Pkd1fl/- mouse. The offspring were viable and developed cystic kidneys 
with increased levels of blood urea nitrogen (BUN), cell proliferation and upregulation of 
components of the MAPK/ERK pathway (164). 
Oak ridge polycystic kidney mice (ORPK): The ORPK mouse model provided the first 
functional link between ciliary defects and the phenotype of polycystic kidneys (110, 165). It 
was discovered by the Oak Ridge National Laboratory in a large-scale insertion mutagenesis 
program and resembles the human ARPKD phenotype (160). The animals develop bilateral 
polycystic kidneys which are enlarged, contain multiple cysts and present destruction of the 
surrounding parenchyma.  
Kif3a knockout mouse: The whole body knockout of Kif3a, a kinesin II subunit 
important for ciliogenesis, during development results in the absence of the primary cilium in 
the embryonic node, leads to situs inversus and abnormalities of the neural tube and is 
therefore lethal before renal organogenesis starts (166-168). The specific deletion of Kif3a in 
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renal tubular cells during embryonic development led to the birth of animals with cystic 
kidneys (166). The epithelial cells lining the cystic regions lost their primary cilium due to 
inactivation of Kif3a. They show an increased proliferation, apoptosis, elevated levels of ß-
catenin and c-Myc and decreased p21 (166). Interestingly, the severity of the cystic 
phenotype can be modulated depending on the time of Kif3a deletion. Embryonic kidney-
specific deletion leads to a rapid onset of the disease and the animals have to be euthanized 
around 3-4 weeks of age due to renal failure (94, 166). Deletion of Kif3a in neonatal animals 
resulted in generation of cysts within the first 4 weeks of life and deletion after P11 leads to 
the development of slowly progressing cysts that first become visible at around 6 months of 
age (94, 142). We took advantage of these rapid and slow onset models of cyst formation in 
the studies described in this thesis. 
IFT140: Embryonic deletion of Ift140, a member of the IFT complex A responsible for 
retrograde transport, impairs proper ciliary function in collecting ducts (169). These animals 
develop polycystic kidneys at day 5 with rapid cyst progression while ciliary assembly was 
not completely abrogated. In addition, increased expression of Wnt pathway genes and Hh 
mediators was observed. The precystic cells had an increased mitotic index while no effect 
on spindle orientation was found. Therefore the authors concluded that increased 
proliferation with dysregulation of Wnt and/or Hh signaling is causative for cyst development 
in this model. 
BBS2 knockout mouse: Bardet-Biedl syndrome is a heterogeneous human disorder 
presenting with obesity, retinopathy, renal and cardiac malformation. In 2004, a Bbs2 
knockout mouse was generated (170). Bbs2 is a member of the BBSome which is required 
for ciliogenesis (171). The function of the BBSome is linked to the Rab8 GDP/GTP exchange 
factor that is important for the elongation of the ciliary membrane (171). Constitutive deletion 
of Bbs2 leads to a resemblance of human BBS in mice (170). Besides obesity, the animals 
exhibit phenotypes of ciliary dysfunctions including retinopathy, renal cysts and impaired 
olfaction (170).  
1.3 pVHL and the primary cilium 
There is evidence that a subset of ccRCC in patients with VHL disease is preceded by 
premalignant cysts (172). The kidney cysts containing these micro-foci of ccRCC resemble 
classical ADPKD (63). In general, PKD is linked to mutations affecting the primary cilium or 
centrosomes. Since VHL disease leads to kidney cysts and ciliary defects are linked to cystic 
disease this led to the idea that pVHL might also be important for the function of the primary 
cilium. Indeed, it was shown that pVHL is localized to the primary cilium and it is essential for 
ciliary assembly (25, 173-175). pVHL interacts with Kif3a and Kap, members of the kinesin-2 
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family, and co-localizes to the primary cilium (176, 177). pVHL is associated with 
microtubules and plays a role in microtubule stabilization in vivo (34). The microtubule 
stabilization function of pVHL depends on a specific domain overlapping with a mutational 
hot spot in VHL disease. The fact that certain naturally occurring mutations exhibit altered 
microtubule stabilization implies a connection to VHL-associated tumor suppressor activity 
(34). In addition, it was shown that naturally occurring pVHL variants unable to bind Kif3a or 
Kap were associated with a reduced frequency of primary cilia while HIF1α function was not 
impaired (178). Furthermore, it was shown that pVHL is involved in mitotic spindle orientation 
through direct interaction with an atypical protein kinase C complex (Par3-Par6-aPKC) (144, 
145, 175, 179, 180). These data link pVHL to cyst formation and cilia function in the kidney, 
which is known to be dependent on members of the kinesin-2 family (Kif3a, KAP).  
An animal model with Vhl deletion in proximal tubule cells of the kidney showed cyst 
formation at a low frequency in old animals (19). The observed low frequency of cyst 
formation is in line with the data of patients with VHL disease that the majority of VHL mutant 
cells remains quiescent and does not automatically form cysts and leads to the conclusion 
that additional mutations must occur to lose the primary cilium in a Vhl-/- background. 
Together, pVHL and GSK3ß were shown to be components of a microtubule regulatory 
network that is involved in the maintenance of the primary cilium (51). First clues for GSK3ß 
function in the primary cilium came from the observation that GSK3ß was required for 
formation and length control of flagella in Chlamydomonas reinhardtii (181). In addition, it 
could be shown that GSK3ß can inhibit the microtubule stabilizing function of pVHL (182). 
This led to the discovery that GSK3ß, when active, maintains the primary cilium while 
inactivating the microtubule stabilizing function of pVHL. If GSK3ß is inactive the inhibition on 
pVHL is lost and therefore pVHL is able to preserve the primary cilium (51).  
In line with these cell culture based observations, cystic regions of VHL disease 
patients show a hyperactivated PI3K pathway (20). This activation is able to cause inhibitory 
phosphorylation of GSK3ß through AKT and p70S6K (183, 184). Activation of PI3K signalling 
is often mediated by loss of its negative regulator Phosphatase and tensin homolog (PTEN) 
and indeed reduced PTEN levels as well as AKT activation correlate with poor prognostic 
outcome in sporadic cases of ccRCC (52, 185). Combined deletion of Vhl and Pten in the 
mouse resulted in cyst formation in the kidney displaying a reduced frequency of primary cilia 
and elevated levels of AKT and ERK signaling as well as inhibitory phosphorylation of 
GSK3ß (20). Taken together, these studies indicate that there is an important role of the 
primary cilium in VHL disease. Work in this thesis tests the hypothesis that has arisen from 
these studies, namely that cooperation between loss of the primary cilium and loss of Vhl is 
able to induce the formation of ccRCC or ccRCC precursor lesions. 
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1.4 Micro-computed Tomography (µCT) 
In this study we have developed a new non-invasive imaging protocol based on computed 
tomography (CT) that allowed quantitative longitudinal monitoring of cysts in living mice. CT 
is a 3D x-ray imaging method to obtain x-ray projection images around the axis of an object 
to generate a stack of thin tomographic images of contiguous slices through the object. CT is 
a widely used technique for diagnostic and therapeutic purposes in a broad range of medical 
areas. Micro-computed tomography (µCT) was first developed in the early 1980s (186). 
There are different levels of small scale CT based on their spatial resolutions: mini-CT, 
micro-CT and nano-CT (187). The pixel resolution of µCT is usually in the micrometer range. 
In general, there are two different setups for these devices: a stationary source and detector 
where a specimen is rotated in the light beam or a stationary specimen where the beam and 
detector are rotated around it (188). For living animals the latter option is commonly used. In 
the past, the majority of analysis were performed with ex vivo specimen but nowadays µCT 
imaging can be used to study in vivo processes longitudinally in an animal such as 
metastasis (189), myocardial infarction (190), kidney volume (191) and even embryogenesis 
(192). In µCT imaging, contrast is produced by the attenuation of X-rays in the examined 
sample therefore offering a good image quality for elements with a high atomic number such 
as bones, but very little soft tissue contrast (193). To achieve a good imaging quality in soft 
tissues the administration of a contrast agent is desirable and often indispensable. Water-
soluble, non-ionic iodine-based contrast agents such as Visipaque are commonly used in 
humans and are quickly eliminated from the blood after intravenous injection through the 
kidney. In contrast to humans, rodents possess a very short circulation time and the contrast 
agent is cleared within seconds from the blood (194). This led to the need of continuous 
injection of a contrast agent during the scanning time (195). Since the new devices have a 
read out of 30-60 fps and the scanning duration is strongly decreased, for specific indications 
a single bolus injection of contrast agent is now sufficient to analyze the sample. We show 
that state of the art µCT imaging is suitable for longitudinal studies of renal cyst formation 
and progression. 
1.5 3D Cell culture of primary kidney epithelial cells 
In this study we have developed a 3D culture system for primary renal epithelial cells. Three 
dimensional (3D) cell culture models provide an approach to study processes like tissue 
morphogenesis and tumourigenesis and might close the gap between standard 2D cell 
culture and animal models. Yamada and Cukierman review the advantages and 
disadvantages of 3D cell cultures and highlight signaling pathways that are differentially 
regulated in 3D cultures compared to 2D cell cultures including growth factor signaling, cell 
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survival and cell polarity (196). 3D cell cultures can be used with a single cell type or even 
with a mixture of different cell types resembling the in vivo situation. 3D scaffolds are usually 
generated from purified collagen I, synthetic biomaterials or Matrigel®. Matrigel® is a 
heterogeneous composition of different extracellular matrix proteins that is produced and 
secreted by Engelbreth-Holm-Swarm (EHS) mouse sarcoma cells and sold by Corning Life 
Science. Different research groups showed that epithelial cell lines are able to form polarized 
acini with a lumen in 3D cell cultures (197-199). In addition, it was shown that kidney-derived 
cell lines and even isolated primary rat kidney epithelial cells were able to form structures in 
a 3D environment (198, 200-202). Furthermore, induced cyst formation in a collecting duct 
3D model by elevating cellular cAMP levels was shown (202). Nonmalignant mammary cells 
form polarized and growth-arrested acini in a 3D assay whereas the malignant cell types 
form non-polarized, proliferating colonies (203). This indicates that the formation of 3D 
structures serves as a growth inhibiting signal for non-transformed epithelial cells in vitro. 
This suppressive environment can be overcome by addition of growth factors or intrinsic 
oncogenic events. The expression of oncogenic Erb2 in a single cell per acini enables the 
cell to overcome the suppressive influence of the acini (199). These studies argue that 3D 
culture models are superior to 2D models in reflecting the epithelial environment and 
studying the initial events involved in tumour formation. For renal derived cells it could be 
shown that stimulation with HGF (hepatocyte growth factor) leads to tubule formation in 3D 
assays (200, 202). Several renal kidney epithelial lines are available but so far no primary 
cell-based 3D assay is available. The ability to utilize primary epithelial kidney cells (pKECs) 
in a 3D assay would in general be a useful technique allowing researchers to take advantage 
of all the available genetically modified mouse lines. 
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1.6 Aims 
 
1. Generation of inducible kidney epithelial cell-specific deletion of Vhl and Kif3a alone 
and together to study their potential cooperative effects on cyst formation and ccRCC 
development. 
2. Generation of an inducible kidney epithelial cell-specific combined deletion of Hif1a 
and Kif3a to study the role of Hif1α in cystogenesis. 
3. Developing a µCT-based non-invasive method for longitudinal quantitative monitoring 
of cyst formation and progression in mice. 
4. Generation of a primary cell-based 3D culture system to study cellular and molecular 
mechanisms of cyst formation/progression and cell transformation ex vivo. 
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2 Materials and Methods 
2.1 Materials 
2.1.1  General Chemicals  
Reagent Supplier 
30% Acrylamide/Bisacrylamide Solution Bio-Rad 
4′,6-Diamidino-2-phenylindole dihydrochloride (DAPI) Sigma-Aldrich 
Acetic acid (glacial) Merck 
Acetone Sigma-Aldrich 
Agarose, D1 low EEO Conda 
Albumin from bovine serum Sigma-Aldrich 
Ammonium carbonate Sigma-Aldrich 
Ammonium chloride Fluka 
Boric acid Sigma-Aldrich 
Bovine serum albumin (BSA) Invitrogen 
Bromophenol blue Sigma-Aldrich 
Citric acid monohydrate Sigma-Aldrich 
Dimethylsulfoxide (DMSO) Sigma-Aldrich 
di-sodium hydrogen orthophosphate (Na2HPO4) Sigma-Aldrich 
Dithiothreitol (DTT) Sigma-Aldrich 
Entellan Merck 
Eosin 1% (aqueous) BioSystems 
Ethanol AUL 
Ethidium bromide  Sigma-Aldrich 
Ethylenediamine tetra-acetic acid (EDTA) disodium salt 
dihydrate 
Sigma-Aldrich 
Formalin 10%, neutral buffered Sigma-Aldrich 
Glycerol Sigma-Aldrich 
Haematoxylin (Mayer’s) J.T.Baker 
Hydrochloric acid, 32%  Sigma-Aldrich 
Hydrogen peroxide Sigma-Aldrich 
Isopropanol AUL 
Magnesium chloride Sigma-Aldrich 
Magnesium sulfate Sigma-Aldrich 
Methanol AUL 
Mineral oil Sigma-Aldrich 
Mowiol  Sigma-Aldrich 
N,N,N’,N’-Tetramethylethylenediamine (TEMED) Bio-Rad 
N-2-Hydroxyethylpiperazine-N’-2-ethanesulfonic acid 
(HEPES) 
Sigma-Aldrich 
NP-40 Sigma-Aldrich 
Paraformaldehyde Sigma-Aldrich 
p-coumaric acid Sigma-Aldrich 
Phenyl-methyl-sulphonyl-fluoride (PMSF) Sigma-Aldrich 
Potassium acetate  
Potassium chloride Sigma-Aldrich 
Protease inhibitor cocktail Sigma-Aldrich 
Protein assay Dye Reagent Bio-Rad 
Safflower oil Migros 
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Reagent Supplier 
Sodium acetate Sigma-Aldrich 
Sodium azide Sigma-Aldrich 
Sodium chloride Sigma-Aldrich 
Sodium deoxycholate Sigma-Aldrich 
Sodium dihydrogen orthophosphate (NaH2PO4) Sigma-Aldrich 
Sodium Dodecyl Sulfate (SDS) Sigma-Aldrich 
Sodium hydroxide Sigma-Aldrich 
Sulforhodamine B sodium salt (SRB) Sigma-Aldrich 
SYBR FAST Universal 2X qPCR Master Mix KapaBiosystems 
Trichloroacetic acid Sigma-Aldrich 
Tris(hydroxymethyl)aminomethane (Tris base) Sigma-Aldrich 
Tris(hydroxymethyl)aminomethane hydrochloride (Tris HCl) Sigma-Aldrich 
Tri-Sodium citrate Sigma-Aldrich 
Triton X-100 Sigma-Aldrich 
Tween-20 Sigma-Aldrich 
Visipaque® 270  GE Healthcare 
Xylene Thommen-Furler AG 
 
2.1.2 Drugs & tissue culture reagents 
Reagent  Supplier 
2−Mercaptoethanol Bio-Rad 
2´,7´-dichlorodihydrofluorescein diacetate Invitrogen 
3,3,5 Triiodothyronine (T3) Sigma-Aldrich 
Ampicillin Sigma-Aldrich 
Apo-Transferrin (TF), human Sigma-Aldrich 
Calcium chloride Sigma-Aldrich 
Collagenase Type II Gibco 
D-glucose Sigma-Aldrich 
DMEM/F12 Sigma-Aldrich 
Dulbecco’s Modified Eagle Medium (DMEM) Sigma-Aldrich 
Epidermal Growth factor (EGF), murine PeproTech 
Fetal Calf Serum (FCS) Biochrome AG 
HBSS Gibco 
Hepatocyte Growth factor (HGF) PeproTech 
HEPES 1M Sigma-Aldrich 
Hydrocortisone (HC) Sigma-Aldrich 
Insulin, human Sigma-Aldrich 
L-Glutamine Sigma-Aldrich 
Matrigel® (growth factor reduced) Corning 
Penicillin/Streptomycin PAA 
Phosphate Buffered Saline (PBS) Biochrome Ag 
Prostagladin E1 (PGE1) Sigma-Aldrich 
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Reagent  Supplier 
Puromycin InvivoGen 
Sodium bicarbonate Sigma-Aldrich 
Sodium Selenite (SS) Sigma-Aldrich 
Tamoxifen Sigma-Aldrich 
Trypsin EDTA Gibco 
Trypsin inhibitor, soybean Gibco 
 
2.1.3 Kits 
Name Supplier 
ABC Kit (PK6100) Vectorstain 
Avidin/Biotin Blocking Kit (SP 2001) VectorLaboratories 
CellTiter-Glo Luminescent Cell Viability Assay Promega 
CSA detection kit Dako 
DAB Substrate Kit (SK-4100) VectorLaboratories 
Glucose assay Kit II Biovision 
Lactate assay Kit II Biovision 
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2.1.4 Antibodies and Lectins 
Name Vendor Order number Source Dilution Application 
β-Actin (AC-74) Sigma-Aldrich A2228 Mouse 1:1000 WB 
AE1 Gift from Wagner 
Lab 
- Rabbit 1:250 IF 
Alexa-488 Anti-
mouse 
Life technologies A11029 Goat 1:1000 IF 
Alexa-488 Anti-
rabbit 
Life technologies A11008 Goat 1:1000 IF 
Alexa-488 Anti-rat Life technologies A11006 Goat 1:1000 IF 
Alexa-568 Anti-
mouse 
Life technologies A11031 Goat 1:1000 IF 
Alexa-568 Anti-
rabbit 
Life technologies A11036 Goat 1:1000 IF 
Alexa-568 Anti-rat Life technologies A11077 Goat 1:1000 IF 
Aquaporin 2 Gift from Loffing 
Lab 
- Rabbit 1:3500 IF 
ATP V1B1 Gift from Wagner 
Lab 
- Rabbit 1:250 IF 
E-Cadherin Abcam Ab11512 Rat 1:200 IF 
Fluorescein labeled 
Dolichos Biflorus 
Agglutinin (DBA) 
Vector Labs FL-1031 - 1:250 ICC/IF 
Fluorescein labeled 
Lotus 
Tetragonolobus 
Lectin (LTA) 
Vector Labs FL-1321 - 1:250 ICC/IF 
Glut1 Abcam Ab14683 Rabbit 1:500 WB/IF 
HIF1α (H1α67) Novus 
Biotechnologies 
NB-100-105 Mouse 1:20000 IHC 
phospho-Histone H3 
(Ser-10) 
Santa Cruz 
Biotechnologies 
sc-8656-R 
 
Rabbit 1:250 IF 
HRP anti-mouse ThermoScientific 31430 Goat 1:1000 IHC 
HRP anti-rabbbit ThermoScientific 31460 Goat 1:1000 IHC 
Kif3a Abcam Ab11259 Rabbit 1:2000 WB 
NaPi2 Gift from Biber 
Lab 
- Rabbit 1:500 IF 
NCC Millipore AB3553 Rabbit 1:500 IF 
NKCC2 Gift from Loffing 
Lab 
- Rabbit 1:250 IF 
Pendrin Gift from Wagner 
Lab 
- Rabbit 1:250 IF 
Tamm Horsfall 
Protein (H-135) 
Santa Cruz 
Biotechnologies 
Sc-20631 Rabbit 1:250 IF 
Tubulin, acetylated Sigma-Aldrich T6793 Mouse 1:1000 IF 
Vhl (FL-181) Santa Cruz 
Biotechnologies 
Sc-5575 Rabbit 1:100 WB 
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2.1.5 Oligonucleotide sequences 
Name Sequence Application 
IF008 ctrl fwd ATA ATG CCT TTC CTC AGT AAA CCA 
G 
Genotyping 
IF009 ctrl rev GGA TCC CAT TAC AGA TGG TTG TG Genotyping 
IF054 KspCre fwd AGG TTC GTG CAC TCA TGG A Genotyping 
IF055 KspCre rev TCG ACC AGT TTA GTT ACC C Genotyping 
IF77 Vhl fwd1 CTG GTA CCC ACG AAA CTG TC qPCR 
IF78 Vhl fwd2 CTA GGC ACC GAG CTT AGA GGT TTG 
CG 
qPCR 
IF79 Vhl rev CTG ACT TCCACT GAT GCT TGT CAC 
AG 
qPCR 
IF163 p53 fwd GCC CTC TCT TAT CGC CAG AT Genotyping 
IF164 p53 rev GCT TAT GGG CTT CTC CAA ACT Genotyping 
IF249 HIF1a fwd GGA GCT ATC TCT CTA GAC C Genotyping / qPCR 
IF250 HIF1a rev GCA GTT AAG AGC ACT AGT TG Genotyping / qPCR 
IF251 HIF1a fl F TGG GGA TGA AAA CAT CTG CT qPCR 
IF252 HIF1a fl R GTT GGG GCA GTA CTG GAA AG qPCR 
IF302 Kif3a P1 AGG GCA GAC GGA AGG GTG G Genotyping / qPCR 
IF303 Kif3a P2 GGC AGA TGG ATC TCT GTG AGT TTG Genotyping / qPCR 
IF419 Vhl fwd GGA GTA GGA TAA GTC AGC TG Genotyping  
IF420 Vhl rev GTA CAC CTG AGA GCG GCT TC Genotyping  
IF732 rpS6 
promoter rev 
AGT CAC TTC CGC CGG CTG TTC qPCR 
IF731 rpS6 
promoter fwd 
GCG TCA CGA AAA AGA GGC CCG A qPCR 
IF739 Kif3a rec fwd GCA GAC GGA AGG GTG GTT TA qPCR 
IF740 Ki3a rec rev CTG CAA GAGGGT GGA AAG GA qPCR 
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2.2 Cell culture 
2.2.1 Culture of MEFs 
MEFs were isolated from embryos of relevant floxed strains at E13.5. After removing the 
head, internal organs and spinal cord the remaining tissue was minced with a razorblade, 
incubated for 15 minutes at 37°C in trypsin EDTA, dispersed in growth media (DMEM 
supplemented with 10% FCS, 2mM glutamine, 1% Pen/Strep and 200 µM β-
mercaptoethanol) and plated on a 10cm dish. Cells were split 2-3 days later into two 15cm 
dishes and after additional 2-3 days they were frozen at passage 2. Cells were cultured in 
conventional cell culture incubators at 5% oxygen. 
2.2.2 Isolation of primary epithelial kidney cells 
Kidneys of floxed mice were dissected. After removing the capsule under sterile conditions, 
kidneys were mashed with a razor blade on ice and digested in a digestion solution (10mg 
Collagenase Type II, 10mg soybean Trypsin inhibitor in 20ml HBSS with 2% 1M HEPES and 
1% Pen/Strep) at 37°C for 30min with frequent agitation. The cell suspension was filtered 
through a 70µm sieve and washed with HBSS + 5% FCS. After erythrocyte lysis in standard 
ACK buffer (NH4Cl 151,4µM, KHCO3 10µM, EDTA Na2·H2O 12,75µM), the cells were 
resuspended in K1 medium (DMEM/F12 supplemented with 1% Pen/Strep, 1%L-Glutamin, 
HEPES 25 mM, Insulin 5 µg/ml, PGE1 1,25 ng/ml, T3 34 pg/ml, Apo-Transferrin 5 µg/ml, 
sodium selenite 1,73 ng/ml Hydrocortison 18 ng/ml and EGF 25 ng/ml) Cells were seeded at 
a density of 1x106 cells/10cm dish. The medium was changed after 4 days for the first time 
and every 3rd day thereafter. If desired, cells were transduced with Adeno-eGFP or Adeno-
Cre-GFP after 5-6 days in culture.  
2.2.3 Proliferation assays 
For proliferation assays for MEFs, cells were seeded at densities of 3x105 cells per 6cm dish 
in triplicate dishes and counted after 3 days before reseeding at the same density for the 
next passage. All proliferation assays shown in the figures are representative of at least 3 
independent experiments. 
For primary kidney cells, a Sulforhodamine B (SRB) colometric assay was performed 
(204). Cells were cultured in K1 medium containing 10% FCS for 2 days before seeding for 
the SRB assay. 2x103 cells per well were seeded and fixed in 5% (wt/vol) trichloroacetic acid 
at the indicated time points. Cells were stained in 0.057% (wt/vol) SRB solution and air dried. 
SRB was solubilized by incubation in 10 mM Tris base solution (pH 10.5) and OD was 
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measured at 540 nm in a microplate reader (Anthos Lucy 3). All SRB assays shown in the 
figures are representative of at least 3 independent experiments. 
2.2.4 3D culture 
To culture primary epithelial kidney cells in a 3D environment we modified a published 
protocol by Lee et al. (205). A 96-well was coated with 5µl of growth factor-reduced Matrigel® 
(Matrigel® GR) for 10 min in a cell culture incubator. Primary epithelial kidney cells were 
grown for ~7 days in K1 medium before starting the 3D culture. 5x104 primary epithelial 
kidney cells were resuspended in 75µl Matrigel GR and seeded in the coated well. After 
solidifying of the Matrigel® in an incubator for 30 min 60µl of K1 medium were added to the 
3D culture. Medium was changed every 3 days. 3D cultures were treated with Adenoviruses 
as indicated in the experiments. Every work step involving Matrigel® was carried out on ice. 
After acini formation the structures were fixed with 4% PFA for 1h at RT followed by three 
times washing with PBS-Glycine (100mM). Cultures were blocked with 100µl of IF blocking 
solution (10% goat serum, 1% goat F(ab’)2 anti-mouse immunoglobulin G, in IF buffer (0.2% 
Triton X-100, 0.1% BSA, 0.05% Tween 20 in PBS pH 7.4, sterilized, add 7.7 mM NaN3 for 
longterm storage)) for 1.5h at RT. 96-Wells were incubated with the primary antibody diluted 
in 50µl IF buffer for 2h at RT. After washing three times with 200µl IF buffer for 20 min, the 
wells were incubated with a secondary antibody diluted in 50µl IF buffer for 45min at RT. 3D 
cultures were washed once with IF buffer and twice with PBS for 20min each before 
counterstaining the structures with DAPI (0.5µg/ml in PBS) for 5min at RT. Matrigel® was 
removed from the well and transferred to a slide for mounting in Mowiol/DABCO. 
2.2.5 ATP measurements 
Cells were trypsinized, counted (Beckman counter Vi-Cell XR and Z2) and 1.5x105 cells were 
resuspended in 75µl PBS and 75µl buffer (CellTiter-Glo Luminescent Cell Viability Assay, 
Promega). Cells were lysed for 10 min at room temperature and distributed as technical 
triplicates in a 96-well plate. Luminescence signal was detected with a microplate reader 
(Anthos Lucy 3). Student’s t-test was performed for statistical analysis.  
  
Materials & Methods 
37 
 
2.3 Molecular and biochemical Methods 
2.3.1 Genomic DNA qPCR-analysis 
FFPE kidney sections were washed 2x1min in Xylol and air dried. Sections were transferred 
to a 1.5ml Eppendorf tube and genomic DNA was isolated with the Arcturus PicoPure DNA 
Extraction Kit (life technologies). The real-time PCR analysis of cDNA was performed with 
SYBR FAST Universal 2X qPCR Master Mix and used primers listed above (2.1.5). 
2.3.2 Western blotting 
Cells were washed with PBS before lysis. Ice-cold RIPA buffer (50 mM Tris–HCl at pH 7.5, 
150 mM sodium chloride, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS, 2mM EDTA, 1 
mM sodium fluoride, 1 mM Na3VO4, 1 mM PMSF, 1 mM dithiothreitol, 1:100 Protease 
Inhibitor Cocktail) was added to the wells, the cells were detached using a cell scraper and 
transferred to a 1.5 ml tube. The cell lysate was centrifuged at 15000 g for 10 min (4°C). The 
Bradford protein assay was used to determine the protein concentration of the supernatant. 
The appropriate amount of denaturing 6x Lämmli buffer was added and the samples were 
boiled at 97°C for 5 min. Samples were either utilized for SDS-PAGE directly or stored at -
20°C for later use. Proteins were run on 6–15% acrylamide gels, transferred to nitrocellulose 
membranes and visualized by semi-dry immunoblotting with antibodies described above. The 
signal was detected using the Fujifilm Luminescent Image Analyzer LAS4000 mini. 
2.3.3 Agarose gel electrophoresis 
For agarose gel preparation, the desired amount of agarose (between 0.7 and 2%) was 
boiled in 1x SBA buffer (0.02M NaOH, 0.04M Boric acid in dest. H2O) and 8µl of ethidium 
bromide were added for a volume of 100 ml. The liquid was poured into a gel casting device 
and allowed to set. The gel was placed in an electrophoresis chamber filled with 1x SBA. The 
DNA samples were mixed with 6x loading buffer (60% 10xSBA, 18% Ficoll type 400, 0.12mM 
EDTA pH 8.0, 0.15% Bromphenol blue and 0.15% Xylencyanol FF in dest. H2O) and loaded 
onto the gel. An electric potential of 100 V was applied for electrophoresis and the DNA 
bands were visualized using a UV light transilluminator at 366 nm. 
2.4 Animal and tissue handling 
2.4.1 Mouse strains 
Mice expressing a tamoxifen inducible kidney-specific Cre recombinase under the Ksp1.3 
promoter (206) were crossed with mice containg loxP sites flanking exon 2 of the Kif3a gene 
(166) and or mice containing loxP sites flanking exon 1 of the Vhl gene (207) generating the 
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following lines: KspCreERT2 Tg/+;Kif3afl/fl , KspCreERT2 Tg/+;Vhlfl/fl and KspCreERT2 Tg/+;Kif3afl/fl;Vhlfl/fl. 
Tamoxifen (TM) treated Cre recombinase expressing mice will be called Kif3a∆/∆, Vhl∆/∆ and 
Kif3a∆/∆Vhl∆/∆, whereas TM treated Cre negative mice will be referred as Kif3a+/+, Vhl+/+ and 
Kif3a+/+Vhl+/+, respectively. For generation of KspCreERT2 Tg/+;Kif3afl/fl;Hif1afl/fl we used a mouse 
line with loxP sites flanking exon 1 of the Hif1a gene (208). Wild type cells were isolated from 
C57BL/6 embryos. 
2.4.2 Genotyping 
Ear biopsies were digested for 15 min at 95°C in lysis buffer (25 mM NaOH, 0.2 mM EDTA, 
pH 12) and neutralized afterwards with the same amount of neutralisation buffer (40 mM 
Tris-HCl, pH 5). PCR was carried out according to standard procedures using JumpStart Taq 
DNA polymerase and primers shown in table 0. The DNA was analyzed on 1.5% agarose 
gels in SBE buffer (5 mM NaOH bufferd with boric acid, pH 8.5). 
2.4.3 Tamoxifen treatment 
Tamoxifen was administered to induce Cre/loxP recombination in Ksp1.3-CreERT2 transgenic 
mice. Tamoxifen was dissolved in 100% ethanol then diluted 10-fold in corn oil to a final 
concentration of 20 mg/ml. To induce recombination in newborn mice, nursing dams were 
injected with tamoxifen (4 mg/40 g body weight) on post-partum days 2–4. Recombination in 
6 week old adult animals was achieved by changing the diet to Tamoxifen-containing pellets 
for 2 weeks. Non-Cre transgenic littermate mice served as controls for all cohorts. 
2.4.4 Tissue collection and procedure  
Mouse tissues were immersion-fixed in 10% formalin at 4°C overnight and stored in 70% 
ethanol. After dehydration in serial dilutions (3 h 70% EtOH, 2 h 80% EtOH, 2 h 90% EtOH, 2 
h 96% EtOH, 2 h 100% EtOH, 2 h xylene, 3 h paraffin at 65°C), organs were embedded in 
paraffin and cut into 5 µm sections and fixed on polysine glas slides (VWR). 
2.4.5 micro Computed Tomography (µCT) 
Animals were anaesthetized and Visipaque® 270 (GE Healthcare) was injected i.v. at 8µl/g 
bodyweight (191) as contrast agent in a single bolus injection. µCT images were recorded 
with a Quantum FX microCT (Perkin Elmer) and the following settings: 100µA, 90kV, 
respiratory gating and fine scanning. µCT data were exported as DICOM images to be 
analyzed manually with the Myrian® software (intrasense®) for volumetric measurements and 
3D reconstruction and in the Quantum FX data format for overview X-ray pictures. 
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2.4.6 Blood collection and analysis 
Animals were anaesthetized and blood was terminally collected by puncture of the heart and 
treated with sodium-heparin. Blood plasma was stored at – 80°C for further analysis. 
Creatinine and blood urea nitrogen (BUN) were determined using the UniCel® DxC 800 
Synchron® Clinical System in cooperation with the ZIRP (University of Zürich).  
2.5 Histological analysis  
2.5.1 Haematoxylin and Eosin (H&E) staining   
Tissue sections were dewaxed for 3 min in xylene and hydrated for 2 min each in serial 
dilutions of ethanol washes (100%, 95%, 70%). Nuclei were stained for 4 min in 
haematoxylin and dipped 3 times in 0.3% acid alcohol for differentiation. Proteins were 
stained for 8 min in 1% eosin solution. Finally, specimen were dehydrated for 2 min in serial 
ethanol dilutions (70%, 95%, 100%) and xylene (3 min) and mounted in entellan. 
 
2.5.2 Immunohistochemistry 
Tissue sections were dewaxed in xylene and hydrated in series of ethanol washes (10 min 
xylene, 10 min 100 % EtOH, 10 min 95% EtOH, 5 min in 70% EtOH) and washed for 5 min in 
PBS-T (137 mM NaCl, 2.7 mM KCl, 19 mM Na2HPO4, 1.7 mM KH2PO4, pH 7.4, 0.3% Triton 
x-100). For antigen retrieval, slides were cooked for 5 min at 110°C in 0.1 M citrate buffer 
(pH 6) using a standardized pressure cooker (HistosPro, Milestone). Immunohistochemistry 
targeting Hif1α protein was performed using the Dako Catalyzed Signal Amplification (CSA) 
kit according to the manufacturer’s instruction. The following changes were included in the 
protocol: After peroxidase block, specimen were incubated for 15 min in avadin solution 
(TBS, supplemented with 1% BSA, 0.1% Tween, 2 drops avadin solution per 250 µl solution), 
followed by 15 min biotin solution (TBS, containing 1% BSA, 0.1% Tween 20 and 2 drops 
biotin solution per 250 µl solution). For washing, standard TBS-T (50 mM Tris, 150 mM NaCl, 
0.1% Tween 20) was used before primary antibody incubation, whereas high salt TBS-T 
(0.05 M Tris-HCl pH 7.6 containing 0.3 M NaCl and 0.1 % Tween 20) was used afterwards. 
Rehydration of sections and counterstaining was performed as described in 2.5.1. 
2.5.3 Immunofluorescence (Tissues) 
For immunofluorescence, specimen were processed as described above (2.7.2), however, 
the avadin/biotin block was not performed. After primary antibody incubation, sections were 
incubated with fluorophor-labelled secondary antibodies for 1 h. Subsequently, slides were 
washed with PBS and nuclei were stained for 10 min with DAPI (0.5 ng/ml in PBS containing 
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10% goat serum). After washing in PBS and ddH2O, sections were mounted in 
Mowiol/DABCO. 
2.5.4 Immunocytochemistry 
Cells were cultured on round glass cover slips in a 6-well plate to perform 
immunofluorescence on cells grown in vitro. After washing with PBS the cells were fixed in 
4% PFA for 1 h at room temperature. Removal of PFA is followed by a washing step. The 
cover slips were incubated with blocking solution (see 10% goat serum/0.3% Triton/PBS) for 
1 h at room temperature. Incubation with subsequent antibodies was carried out as 
described in 2.5.3. 
2.5.5 Image acquisition and procession 
Brightfield and fluorescence microscopy was performed on either a Zeiss Scope A1 
microscope or an Axiovert 40 CRC microscope. Images were obtained with an Axiocam 
MRc5 camera using the Axiovision LE64 software and processed with Adobe Photoshop. 
Confocal microscopy was performed on a Leica SP5 at the ZMB of the University of Zurich 
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3 Results 
3.1 Simple and atypical kidney cyst formation results from the 
cooperative effects of deletion of Vhl and loss of the primary cilium 
Manuscript in preparation 
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Abstract 
A subset of familial and sporadic clear cell renal cell carcinomas (ccRCC) is believed to 
develop from cystic precursor lesions. Loss of function of the von Hippel-Lindau (VHL) tumor 
suppressor gene sensitizes renal epithelial cells to lose the primary cilium in response to 
specific signals. Since the primary cilium suppresses renal cyst formation, loss of the cilium 
may represent an initiating event in the formation of ccRCC. To test this idea, we analyzed 
the consequences of inducible renal epithelial-specific deletion of Vhl together with ablation 
of the primary cilium via deletion of Kif3a. We developed a micro-CT-based imaging 
approach to allow quantitative longitudinal monitoring of cystic burden in living animals, 
revealing that loss of Vhl and loss of Kif3a cooperatively shortened the latency of cyst 
initiation, increased the number of cysts per kidney and increased the total cystic burden. In 
contrast to findings in other cystic models, cysts in Kif3a mutant mice did not display 
accumulation of HIF1α and deletion of Hif1a together with Kif3a did not affect cyst 
development or progression, arguing against an involvement of HIF1α in promoting renal 
cyst growth in general. Vhl/Kif3a double mutation also increased the frequency of cysts that 
displayed multilayered epithelial growth, which correlated with an increased frequency of 
misoriented cystic epithelial cell divisions. Thus, loss of Vhl and loss of primary cilia 
cooperatively induce the formation of simple and atypical cysts that resemble ccRCC 
precursor lesions but these cysts do not progress to form tumors.  
 
 
Significance statement 
The sequence of molecular and cellular alterations that lead to clear cell renal cell carcinoma 
(ccRCC) are unclear. Using mouse genetics, we show that deletion of the von Hippel-Lindau 
tumor suppressor gene, which is inactivated in 90% of cases of human ccRCC, in 
combination with loss of the primary cilium, a structure that functions as a cellular antenna to 
suppress uncontrolled kidney cell proliferation, causes the formation of kidney cysts that 
resemble suspected precursor lesions of ccRCC. These findings shed light on the first steps 
of formation of the most frequent form of kidney cancer. Our development of a method 
allowing quantitative monitoring of kidney cysts in living mice will facilitate future studies of 
cystic kidney diseases. 
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Introduction 
von Hippel-Lindau (VHL) disease is an autosomal-dominant genetic disorder caused by 
inheritance of a mutant allele of the VHL gene. Amongst other disease manifestations, VHL 
patients have an increased risk of developing renal cysts and bilateral, multifocal solid or 
cystic clear cell renal cell carcinomas (ccRCC), in which the wild type VHL allele is invariably 
lost due to somatic mutation or gene silencing (1). Kidneys of VHL patients typically develop 
a spectrum of lesions harboring biallelic VHL inactivation that likely represent precursor 
lesions of solid and cystic ccRCC, including small foci of micro-ccRCC with a solid 
appearance, simple cysts that are lined by a single layer of proliferating epithelial cells and 
atypical cysts that contain regions of multilayered or disorganized epithelial growth 
resembling foci of ccRCC (2). These findings have suggested a disease progression model 
whereby ccRCC can form via cyst-dependent and cyst-independent pathways in VHL 
patients (3). The VHL gene is also biallelically inactivated in more than 90% of sporadic 
ccRCC cases (4). While most VHL mutant ccRCCs have a solid morphology, approximately 
5% are termed multilocular cystic renal cell carcinomas that contain cysts with small nodular 
aggregates of clear cell tumor cells within and between the walls of the cysts (5, 6). This 
observation suggests that sporadic ccRCC might also arise via cyst-dependent and cyst-
independent pathways. Acquired cystic kidney disease caused by long-term renal dialysis 
results in an approximately 100-fold increased risk of developing different forms of renal cell 
carcinoma, further emphasizing that renal cysts can be precursors of carcinomas (7). 
 
The protein product of the VHL gene, pVHL, mediates numerous biological activities, 
including targeting the α-subunits of the hypoxia-inducible transcription factors (HIF1α, 
HIF2α, HIF3α) for proteolytic degradation (8) and stabilizing the microtubule network (9). This 
latter function of pVHL appears to be important in the context of the cyst-dependent pathway 
of disease progression through a role of pVHL in regulating the primary cilium. The primary 
cilium is a specialized microtubule-based structure that functions as a sensory organelle for 
numerous chemical and mechanical stimuli (10). Genetic mutations that compromise the 
signaling functions or the structure of primary cilia cause polycystic kidney diseases, the 
most frequent class of genetically-inherited renal diseases, demonstrating that the primary 
cilium acts to suppress uncontrolled proliferation of renal epithelial cells and cyst formation 
(11). Several studies have shown that loss of pVHL function increases the propensity of cells 
to lose their primary cilia (12-15). pVHL localizes to the primary cilium and acts cooperatively 
with GSK3β activity to stabilize the axoneme, the microtubule scaffold of the primary cilium 
(15). Hyperactivation of the PI3K signaling pathway and inactivation of GSK3β in VHL mutant 
cystic lesions in VHL patient kidneys results in loss of maintenance of the primary cilium (15). 
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We previously demonstrated that these cooperative genetic and signaling alterations cause 
loss of the primary cilium and hypothesized that the absence of the cilium is the trigger for 
initiation of cyst formation (3, 15). This concept was supported by mouse studies showing 
that combined kidney epithelial cell-specific deletion of Vhl and Pten together, but not of 
either gene alone, caused renal epithelial cysts that displayed reduced frequencies of ciliated 
epithelial cells (16). A limitation of the conclusions that could be drawn from this study was 
that it was not possible to determine whether cyst formation resulted solely from loss of the 
cilium, from the cooperative effects of loss of the cilium plus loss of Vhl or from cooperative 
effects of loss of the cilium plus loss of Vhl plus activation of the PI3K pathway. Additionally, 
since these mice developed diverse benign malignancies in the genital tract that 
necessitated early euthanasia (17), it was also not possible to age the mice to determine if 
cystic lesions could progress to form ccRCCs. In the current study we address these 
limitations by generating an inducible model of Vhl deletion together with genetic ablation of 
primary cilia through deletion of Kif3a, a component of the kinesin-II microtubule motor 
complex that is necessary for the formation of primary cilia (18). Renal epithelium-specific 
deletion of Kif3a causes a polycystic phenotype, the severity of which depends on the time 
point of deletion. Deletion during embryogenesis or postnatally before day 10 causes rapid-
onset polycystic kidney disease requiring early euthanasia of the animals, while Kif3a 
deletion in animals after P11 results in a slow-onset cystic phenotype emerging at 6 months 
of age (11, 18, 19). We took advantage of a system of inducible gene deletion in adult renal 
epithelia using the Ksp1.3-CreERT2 transgene (19) to allow long-term follow-up of cyst 
progression in kidneys mutant for Vhl and lacking primary cilia.  
 
Loss of pVHL function causes stabilization of HIF1α in cystic lesions in VHL patients (2). 
Recent studies have argued that HIF1α might also play a more general role in cystic lesions 
that arise in genetic conditions other than VHL disease. HIF1α is stabilized in cystic epithelial 
cells due to microenvironmental hypoxia in a rat model of polycystic kidney disease and in 
human polycystic kidney disease tissues (20). Based on studies using two in vitro models of 
cyst formation, it was proposed that HIF1α activation promotes cyst formation (21). However, 
the hypothesis that HIF1α activation may contribute to the formation or progression of cystic 
lesions has not been tested in a physiologically relevant cystic model. In this study we tested 
this idea by deleting Hif1a in the Kif3a-deletion model of kidney cyst formation. 
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Results 
To investigate potential cooperative effects of Kif3a, Vhl and Hif1a deletion on cyst formation 
and malignant transformation we generated mouse lines allowing inducible kidney 
epithelium-specific deletion of Kif3a (Ksp1.3-CreERT2 Tg/+;Kif3afl/fl), Kif3a/Vhl (Ksp1.3-CreERT2 
Tg/+;Kif3afl/fl;Vhlfl/fl) and Kif3a/Hif1a (Ksp1.3-CreERT2 Tg/+;Kif3afl/fl;Hif1afl/fl). Non-transgenic 
(Ksp1.3-CreERT2 +/+) littermates were used as control animals. 6 week-old mice were fed 
tamoxifen-containing food for 2 weeks to induce activation of Cre recombinase. Treated 
animals are hereafter referred to as Kif3a∆/∆, Kif3a∆/∆;Vhl∆/∆ or Kif3a∆/∆;Hif1a∆/∆ and controls 
as Kif3afl/fl, Kif3afl/fl;Vhlfl/fl or Kif3afl/fl;Hif1afl/fl, respectively. Recombination-specific PCR of 
genomic DNA isolated from kidneys revealed that all genes were deleted as expected (Fig. 
1A) and quantitative real-time PCR analysis of recombination at the Kif3a locus revealed a 
similar frequency of recombination in Kif3a∆/∆, Kif3a∆/∆;Vhl∆/∆ and Kif3a∆/∆;Hif1a∆/∆ mice (Fig. 
1B). Renal cysts formed in all genotypes and anti-acetylated tubulin staining of kidneys 
harvested 9 months after tamoxifen feeding showed that epithelial cells lining cysts in 
Kif3a∆/∆, Kif3a∆/∆;Vhl∆/∆ or Kif3a∆/∆;Hif1a∆/∆ mice lacked primary cilia (Fig. 1C), confirming the 
functional effect of Kif3a deletion. Immunohistochemistry using an antibody against HIF1α 
showed nuclear staining in cystic epithelial cells in Kif3a∆/∆;Vhl∆/∆ but not in Kif3a∆/∆ mutant 
mice (Fig. 1C), confirming the efficiency of Vhl deletion. The absence of HIF1α nuclear 
accumulation in cysts in Kif3a∆/∆ mice showed that these lesions are not hypoxic, in contrast 
to results obtained in a rat polycystic kidney model (20). Tubules in Kif3a∆/∆;Vhl∆/∆ mutant 
kidneys in which single or multiple epithelial cells were positive for HIF1α staining (Fig. S1B) 
were observed at a frequency approximately 10-fold higher than the number of cysts. 
Similarly, tubular cells were frequently seen that displayed elevated staining for Glut-1, a 
HIF1α-inducible protein, and concomitant loss of primary cilia, demonstrating deletion of Vhl 
and Kif3a in these cells (Fig. S1H). These tubules harboring Vhl and Kif3a mutant cells 
exhibited no apparent morphological abnormalities, meaning that these cells had not initiated 
cyst formation within 9 months after Vhl and Kif3a were deleted. We conclude that the 
frequency of gene deletion is not the limiting factor in determining the extent of cyst formation 
in these mouse models. Staining with markers of different nephron segments revealed that 
cysts develop from proximal tubules (NaPi), thick ascending loops of Henle (THP), distal 
convoluted tubules (NCC and ATPV1B1), collecting ducts (Aqp2 and ATPV1B1), as well as 
the epithelium at the urinary pole of the glomerulus (Fig. S2), consistent with the expression 
pattern of the Ksp1.3-CreERT2 transgene (19). 
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To quantitatively monitor cyst formation and progression we adapted a µCT-based imaging 
technique involving intravascular injection of a contrast agent that is concentrated via the 
renal tubular system, allowing visualization of the kidney structure (22). We discovered that 
cysts either do not receive the contrast agent or fail to concentrate it and therefore appear as 
dark regions in µCT imaging. All mice were imaged at 8, 16, 20, 24, 28, 32 and 36 weeks 
after administration of tamoxifen food (Fig. 2). Kidneys were isolated and blood plasma was 
taken after the last time point. Visual inspection of the µCT images revealed no cyst 
formation in control animals but that the ∆/∆ genotypes developed kidney cysts over time. 
Kif3a∆/∆ and Kif3a∆/∆;Hif1a∆/∆ animals exhibited a moderate cystic phenotype characterized by 
the development of 2-20 small to medium cysts per kidney. While some Kif3a∆/∆;Vhl∆/∆ mice 
also exhibited an apparent moderate cystic phenotype, many developed a severe phenotype 
and displayed many more larger cysts. Visual comparison of µCT images with histological 
sections of the same kidneys suggested that the µCT imaging approach accurately reflects 
the cystic burden (Fig. 2). A major advantage of this longitudinal imaging approach is that 
total cystic burden can be quantified by 3D reconstruction of the volumes of all of the cystic 
lesions in the entire kidney (Fig. 3A). Compared to Kif3a∆/∆ and Kif3a∆/∆;Hif1a∆/∆ mice, which 
behaved almost identically to one another, Kif3a∆/∆;Vhl∆/∆ mice developed cysts earlier and 
with higher penetrance at all timepoints (Fig. 3B), showed a dramatically increased total 
cystic burden (Fig. 3C) and histological analysis revealed that there were four times the 
number of cysts per kidney section (Fig. 3D). Determination of total kidney volumes using 
µCT demonstrated an excellent correlation with determination of kidney weights (Fig. S3A-C) 
further validating the accuracy of the µCT approach. Analyses of creatinine (Fig. S3D) and 
urea (Fig. S3E) levels in blood plasma revealed that kidney function was only marginally 
impaired in Kif3a∆/∆;Vhl∆/∆ mice with non-significant trends towards increased creatinine and 
urea levels, implying that the µCT imaging approach is able to detect and quantify cystic 
lesions in otherwise fully functioning kidneys. Since the creatinine and urea values for all 
control animals were in the normal ranges, we conclude that monthly rounds of µCT imaging 
over the life of the animal does not compromise kidney function. Moreover, Kif3a∆/∆;Hif1a∆/∆ 
and Kif3a∆/∆;Vhl∆/∆ mice that were fed tamoxifen but not subjected to monthly imaging 
developed cysts similarly to those that were repeatedly imaged (Fig. S4), showing that the 
repeated injection of the contrast agent and µCT imaging does not contribute to the cystic 
phenotype. 
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To compare the proliferative status of epithelial cells in cystic lesions from the different 
genotypes we selected cohorts of mice that displayed a comparable moderate cystic 
phenotype. Ki67 staining was used to label proliferating cells. Some cysts contained 
proliferating cells while others did not (Fig. 4A). Quantifications revealed no differences 
between Kif3a∆/∆, Kif3a∆/∆;Hif1a∆/∆ and Kif3a∆/∆;Vhl∆/∆ mice in terms of the frequency of cysts 
that contained proliferating cells (Fig. 4B) or the frequency of Ki67 positive cells within the 
proliferating cysts (Fig. 4C). The increased cystic number and total cystic burden in 
Kif3a∆/∆;Vhl∆/∆ mice appears to result from an increased frequency of cyst initiation at earlier 
timepoints, rather than an absolute increased rate of growth of cysts. 
 
Since VHL patients develop simple cysts, atypical cysts and ccRCCs, we analysed the 
histological appearance of the cystic lesions in our models. The vast majority of cysts in all 
genotypes were simple cysts lined by a single epithelial layer (Fig. 5A-C). In Kif3a∆/∆ and 
Kif3a∆/∆;Hif1a∆/∆ mutant mice, 1.9% (n=204) and 2.1% (n=282) of cysts, respectively, 
displayed small foci of multilayered or disorganized epithelial growth that projected into the 
lumen of the cyst (Fig. 5A and C). In contrast, in Kif3a∆/∆;Vhl∆/∆ mice the frequency of these 
atypical cysts was 8.0% (n=914) (Fig. 5B). No tumors were observed in these mice.  
 
Several studies have shown that deletion of cyst-suppressing genes early in postnatal 
development while the kidney is actively proliferating induces a more severe and rapid-onset 
cystic phenotype than gene deletion in adult kidneys (11, 19, 23). To achieve early cyst 
formation in a manner that does not compromise overall kidney function, we injected nursing 
dams with a dose of tamoxifen that induced a low level of recombination in the kidneys of 
feeding pups, to induce a limited number of cysts in all genotypes which could be followed 
using µCT imaging for 9 months (Fig. S5). As an additional control, deletion of Vhl alone in 
P2 mice did not cause the development of cysts (Fig. S5), consistent with our previous 
findings using the non-inducible version of the Ksp1.3-Cre transgene, which is expressed 
during embryogenesis and throughout adulthood (16). Staining for HIF1α and anti-acetylated 
tubulin confirmed the functional effects of deletion of Kif3a and Vhl in the relevant genotypes 
(Fig. S6). This method of deletion gave considerable variation within and between litters in 
terms of the extent of cyst formation, precluding meaningful quantitative comparisons of 
cystic burden between the genotypes. Morphological analyses of kidneys 9 months after 
gene deletion revealed very similar phenotypes to adult gene deletion with respect to the 
formation of simple and atypical cysts and absence of tumors. In Kif3a∆/∆ and Kif3a∆/∆;Hif1a∆/∆ 
mutant mice 3.3% (n=333) and 3.5% (n=692) of cysts, respectively, contained regions of 
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atypical epithelial growth (Fig. S7) while 9.3% (n=647) of cysts in Kif3a∆/∆;Vhl∆/∆ mice 
exhibited atypical morphology (Fig. S7). These results collectively show that combined 
mutation of Vhl and Kif3a not only increases the initiation of cystogenesis but also increases 
the frequency of transition to atypical cysts, mimicking the ccRCC precursor lesions that arise 
in VHL patient kidneys. 
 
Cyst initiation in several animal models of loss of function of primary cilia is preceded by 
misorientation of tubular epithelial cell divisions, resulting in cell divisions across the plane of 
the tubule (24). This causes tubular expansion, which is believed to contribute to cyst 
initiation. pVHL regulates the stability of mitotic astral microtubules and is thereby also 
necessary for achieving planar cell division (25). Tubular damage-induced epithelial cell 
proliferation in Vhl mutant kidney tubules leads to an enhanced rate of misoriented cell 
division and correlates with the formation of microcysts in these animals (26). We tested the 
idea that the combined effects of loss of two different mechanisms that normally act to 
ensure oriented cell division could account for the increases in the frequencies of cyst 
initiation and transition to atypical cysts observed in Kif3a∆/∆;Vhl∆/∆ mice. Anaphase cells in 
cystic epithelia of Kif3a∆/∆ and Kif3a∆/∆;Vhl∆/∆ mice were identified by staining for the mitotic 
marker phospho-histone H3 and the plane of cell division was determined by measuring the 
angle between the plane of the cystic epithelium and a line parallel to the midline of the 
separating mitotic chromosome arrays (Fig. 5D). Anaphases in Kif3a∆/∆;Vhl∆/∆ cysts displayed 
a significantly greater spread of angles than anaphases in Kif3a∆/∆ cysts (Fig. 5E). Notably, 
approximately one third of Kif3a∆/∆;Vhl∆/∆ anaphases were oriented more out of the plane of 
the epithelium than within the plane of the epithelium (angle less than 45o) whereas about 
one eighth of Kif3a∆/∆ displayed this phenotype. This increase in frequency of misoriented cell 
division correlates closely with the approximate 3-4 fold increases in cyst number and 
frequency of atypical cysts in Kif3a∆/∆;Vhl∆/∆ compared to Kif3a∆/∆ mice. 
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Discussion 
Despite intensive study, the molecular and cellular mechanisms that underlie the formation of 
ccRCC remain unclear and an autochthonous mouse model of this disease has yet to be 
developed. We previously proposed a model of disease initiation in which loss of the 
microtubule stabilizing function of pVHL in combination with signaling alterations in the PI3K 
and ERK pathways results in failure of epithelial cells to maintain the primary cilium. We 
suggested that loss of this organelle causes pre-neoplastic cyst formation in VHL patients (3, 
15, 16). Our current studies validate this hypothesis but also suggest that a modification of 
the initial primary cilium-centric model of cyst formation is necessary. The observations that 
deletion of Vhl together with deletion of Kif3a shortens the latency of cyst initiation, increases 
the total number of cysts and total cystic burden compared to deletion of Kif3a alone, argue 
that loss of the primary cilium represents a secondary event in VHL mutant cells that 
cooperates with other cellular changes that arise due to loss of pVHL function and that 
together these alterations induce cyst formation.  
 
A second important conclusion of this study is that Vhl/Kif3a-deficient cystic lesions can 
persist for at least 6-9 months in mice without progressing to form tumors. Nonetheless, a 3- 
to 4-fold increase in the frequency of cysts that displayed regions of multilayered epithelial 
growth projecting into the cystic lumen was observed in Kif3a∆/∆;Vhl∆/∆ mice compared to 
Kif3a∆/∆ and Kif3a∆/∆;Hif1a∆/∆ mice. Since simple cysts are believed to progress to atypical 
cysts in the cyst-dependent pathway of ccRCC formation, Kif3a∆/∆;Vhl∆/∆ mice appear to 
accurately mimic ccRCC precursor lesions. It should be noted that while the frequency of 
cyst formation in Kif3a∆/∆;Vhl∆/∆ mice is much higher than that seen in Vhl∆/∆;Trp53∆/∆ mice, 
the degree of atypical growth in the Kif3a∆/∆;Vhl∆/∆ model is much less than that observed in 
Vhl∆/∆;Trp53∆/∆ mice, which displayed atypical cysts characterized by extensive epithelial 
proliferation into the lumen as well as the presence of solid neoplasms that had apparently 
filled the lumen of the cyst (39). This argues that combined loss of the primary cilium plus 
loss of pVHL function represents an initial trigger for the onset of cyst formation and for the 
transition to disorganized epithelial proliferation but that these molecular and cellular 
changes alone are insufficient for sustained neoplastic growth. Additional mutations that 
occur frequently in ccRCC such as PBRM1, BAP1, SETD2 or TP53 or PI3K pathway 
alterations (4, 27) might allow tumor formation from these atypical cystic precursors. 
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Given the diversity of the molecular and cellular processes that are regulated by pVHL (28) 
and by primary cilia (10), it appears likely that multiple mechanisms functioning together 
might underlie the cooperative phenotypes that arise due to Vhl and Kif3a deletion. 
Interestingly, since many normal tubules harboring deletion of Vhl and Kif3a do not form 
cysts within 9 months of gene deletion, it is evident that loss of Vhl together with loss of 
primary cilia does not automatically lead to cyst formation. Rather, it is likely that these 
mutant cells are sensitized to form cysts in response to as-yet-unidentified cues in the kidney 
microenvironment. For example, cellular proliferation following damage to nephrons has 
been shown to trigger cyst formation in adult kidneys that lack a variety of cyst-predisposing 
genes (11, 19, 23). We speculate that the continuous cell turnover that occurs in the adult 
kidney (29) may represent the proliferative events that allow cyst formation by Kif3a- or 
Vhl/Kif3a-deficient cells, with the latter genotype being more sensitized than the former to 
initiate cyst formation. One likely contributing factor to this sensitization is dysregulation of 
planar epithelial cell division. During development, or during repair of a damaged adult 
kidney tubule, cellular divisions normally orient along the length of the tubule, ensuring that 
the tubule lengthens. Misoriented cellular divisions across the plane of the tubule increase 
the diameter of the tubule and this is believed to represent an initial step in cyst formation 
(24). Numerous studies have linked the primary cilium to control of oriented cell division via 
control of non-canonical Wnt and planar cell polarity signaling pathways. Loss of cilia, or of 
several important signaling components of cilia, causes misorientation of cellular division in 
normal tubules before cysts form (reviewed in (24)). In this context, it is interesting that pVHL 
controls the plane of cell division via a different mechanism. pVHL regulates the stability of 
the astral microtubule network that links the mitotic spindle poles to integrin contacts on the 
cell surface, thereby controlling the orientation of the mitotic spindle (25). Genetic deletion of 
Vhl in kidney tubules subjected to ischemic damage to induce cellular proliferation caused an 
increase in the frequency of misoriented epithelial cell divisions, correlating with the 
formation of microcysts in these animals (26). Consistent with the idea that Vhl and Kif3a 
double deletion leads to the loss of two different mechanisms that normally act to ensure 
oriented cell division, anaphases in cystic epithelia of Kif3a∆/∆;Vhl∆/∆ mice were more 
frequently misoriented out of the plane of the cystic epithelium than those in Kif3a∆/∆ mice. 
The expansion of a simple cyst and maintenance of a single epithelial layer requires that 
cells continue to divide within the plane of the cystic epithelium. We propose that the 
transition to multilayered epithelial growth in atypical cysts may occur if cell divisions occur 
perpendicularly to the plane of the epithelial cells that line the cysts, resulting in a daughter 
cell that could grow on top of the existing cystic epithelium. The higher frequency (33%) of 
misaligned anaphases relative to the frequency of atypical cysts (8-9%) in Kif3a∆/∆;Vhl∆/∆ 
mice may potentially be reconciled by the likely failure of a certain fraction of daughter cells 
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to survive if they divide away from contacts with the basement membrane. It may be 
speculated that additional genetic alterations might increase the probability of successfully 
establishing an epithelial outgrowth into the cystic lumen. Misorientation of cellular division 
may also account for the increased frequency of cyst initiation in Kif3a∆/∆;Vhl∆/∆ mice. While 
we were unfortunately unable to test the orientation of cellular division in normal tubules prior 
to cyst initiation due to the relatively low frequency of Cre-mediated recombination and lack 
of a method of detecting the Kif3a and Vhl/Kif3a mutant mitotic cells, it seems plausible to 
suggest that an increased rate of misoriented cell division by Kif3a∆/∆;Vhl∆/∆ tubular epithelial 
cells might result in a more frequent expansion of the diameters of tubules and increased 
cyst initiation.  
 
Another potential mechanism that may contribute to cyst formation is HIFα activation. Vhl 
deletion in mouse proximal tubular epithelial cells using the Pepck-Cre transgene caused 
cyst formation in a small fraction of older mice (30). Since this phenotype could be rescued 
by co-deletion of Arnt, encoding HIF1α, the dimerization partner of HIF1α and HIF2α that is 
necessary for transcriptional activation, but not by co-deletion of Hif1a (30), it is possible that 
the combined activities of HIF1α and HIF2α may promote cyst formation in the Vhl/Kif3a 
deletion model. Indeed, a more general role for HIF1α stabilization in cyst progression has 
been recently proposed (20, 21). In this study however, we find that cystic lesions induced by 
Kif3a deletion are not characterized by HIF1α stabilization nor does the deletion of Hif1a 
have any effect on the formation of cysts in this model. It may be that HIF1α stabilization is 
limited to more severe polycystic kidneys than achieved in this model, or that cellular 
signaling changes induced by mutation of the PKD1/PKD2 genes in autosomal dominant 
polycystic kidney disease contribute to HIF1α activation in cysts in a manner that is not 
reproduced by complete loss of the primary cilium, for example through constitutive mTOR 
activation (31-33), which causes enhanced translation of HIF1α (34, 35). 
 
Finally, these studies have developed and validated a non-invasive method of quantification 
of cystic burden in mice that should prove useful for future studies investigating polycystic 
kidney diseases. Typical experimental approaches currently depend on end-point 
measurements of large cohorts of mice that are sacrificed for analyses at different 
timepoints. Quantification of cystic burdens requires analyses of histological sections and 
therefore represents only a fractional sampling of the cysts in the kidney. The ability to 
longitudinally and quantitatively monitor cystic burdens in entire intact kidneys of cohorts of 
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mice over time will facilitate ongoing efforts to understand the genetic basis of different 
polycystic kidney diseases and to develop effective therapies against these diseases. 
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Materials and Methods 
Animals 
Mice expressing a tamoxifen-inducible kidney-specific Cre recombinase under the Ksp1.3 
promoter (36) were crossed with Kif3afl/fl (18), Vhlfl/fl (37) and/or Hif1afl/fl (38) animals. Gene 
deletion in 6 week-old animals was achieved by feeding with tamoxifen food (400 ppm) from 
Harlan Laboratories for 2 weeks. For gene deletion in P2 animals nursing dams were 
injected intraperitoneally with tamoxifen (0.1 mg/g body weight) from days P2-P4. Mouse 
experiments were conducted under experimental license 131/2012 from the Veterinary Office 
of the Canton of Zurich. Sequences of genotyping primers are given in table S1. 
 
micro Computed Tomography (µCT) 
Visipaque® 270 (GE Healthcare) was injected intraveneously at 8 µl/g body weight as 
described in (22). µCT images were obtained with a Quantum FX microCT (Perkin Elmer) 
with the following settings: 100 µA, 90 kV, respiratory gating and fine scanning. µCT data 
were exported as DICOM images to be analyzed manually with the Myrian® software 
(intrasense®) for volumetric measurements and 3D reconstruction and in the Quantum FX 
data format for overview X-ray pictures. 
 
Immunohistochemistry 
Immunohistochemistry and immunofluorescence of formalin-fixed paraffin-embedded kidneys 
was performed as described (39) with the following antibodies: α-ATPV1B1 (gift from C. 
Wagner), α-Aqp2 (gift from J. Loffing), α-Glut1 (Abcam), α-HIF1α (Novus Biotechnologies), α-
THP (Santa Cruz Biotechnology), α-NaPi (gift from J. Biber), α-NCC (Millipore) and α-
acetylated Tubulin (Sigma-Aldrich). Secondary Alexa-488 or Alexa-568 coupled antibodies 
were from Life Technologies. HRP-coupled α-mouse secondary antibody was from 
ThermoScientific.  
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Genomic DNA qPCR analysis 
Paraffin embedded kidney sections were washed 2 x 1 min in Xylol and air dried. Genomic 
DNA was isolated with the Arcturus PicoPure DNA Extraction Kit (Life Technologies). Real-
time PCR analysis was performed with SYBR FAST Universal 2X qPCR Master Mix and the 
primers are listed in Table S1. 
 
Blood plasma analysis 
Animals were anaesthetized and blood was collected by puncture of the heart and treated 
with sodium-heparin. Creatinine and blood urea nitrogen (BUN) were determined using the 
UniCel® DxC 800 Synchron® Clinical System.  
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Figure Legends 
Figure 1: Generation of mice allowing inducible deletion of Kif3a, Kif3a/Vhl or 
Kif3a/Hif1a. (A) PCR of genomic DNA from kidneys of Kif3a∆/∆ and Kif3afl/fl (top), 
Kif3a∆/∆;Vhl∆/∆ and Kif3afl/fl;Vhlfl/fl (middle) and Kif3a∆/∆; Hif1a∆/∆ and Kif3afl/fl;Hif1afl/fl (bottom) 
mice. PCR reactions using primers specific for the floxed (fl) and recombined (∆) alleles were 
performed (indicated on top) and the positions of the expected products are shown on the 
side. The promoter region of ribosomal protein S6 (S6) served as internal control. (B) 
Quantitative real time PCR analyses of the ratio of the Kif3a recombined (∆) and floxed (fl) 
alleles in kidneys from the indicated genotypes. Mean ± St. Dev. (n=3-7). (C) Representative 
H&E, anti-Hif1α and anti-acetylated tubulin staining of histologically normal and cystic (Cy) 
regions of Kif3a∆/∆, Kif3a∆/∆;Vhl∆/∆ and Kif3a∆/∆; Hif1a∆/∆ kidneys. Scale bars = 20 µM. 
 
Figure 2: Longitudinal imaging of cyst progression. Representative µCT images of wild 
type (A), Kif3a∆/∆ (B), Kif3a∆/∆;Vhl∆/∆ (C) and Kif3a∆/∆; Hif1a∆/∆ (D) mice taken at 8, 16, 28 and 
36 weeks after treatment and corresponding histological section of one kidney (36 weeks) 
from each of the imaged mice. Mice were scored visually as having a moderate or severe 
cystic phenotype and the number of animals of each genotype with each score is shown. 
Scale bar in H&E images = 1 mm. 
 
Figure 3: Quantitative assessment of cystic burden reveals increased cyst formation 
in Kif3a∆/∆;Vhl∆/∆ kidneys. (A) Coronal µCT image and 3D reconstruction of representative 
Kif3a∆/∆, Kif3a∆/∆;Vhl∆/∆ and Kif3a∆/∆;Hif1a∆/∆ kidneys at 36 weeks after treatment. Kidneys 
(yellow) and cysts (red) are shown on top of the x-ray image. (B) Percentage of animals 
displaying kidney cysts in µCT images at different timepoints after gene deletion. Kif3a∆/∆ 
(n=10), Kif3a∆/∆;Vhl∆/∆ (n=16), Kif3a∆/∆;Hif1a∆/∆ (n=9). (C) Quantification of total cystic volume 
per kidney. Mean ± SEM, Kif3a∆/∆ (n=14), Kif3a∆/∆;Vhl∆/∆ (n=30) and Kif3a∆/∆;Hif1a∆/∆ (n=16). 
(D) Number of cysts per kidney section determined by analyses of histological sections 
through the longitudinal midline of kidneys. Mean ± SEM, Kif3a∆/∆ (n=24), Kif3a∆/∆;Vhl∆/∆ 
(n=27) and Kif3a∆/∆;Hif1a∆/∆ (n=17). * p<0.05 and *** p<0.005, Student’s unpaired T-test. 
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Figure 4: Ki67 staining reveals no differences between genotypes in rate of 
proliferation of cystic cells. (A) Examples of cysts from each genotype that either display 
no cells that stain for Ki67 (Ki67-) or that contain Ki67 labelled cells (Ki67+). (B) Percentage of 
cysts that display Ki67 labelled cells, Mean ± SEM, Kif3a∆/∆ (n=54), Kif3a∆/∆;Vhl∆/∆ (n=56), 
Kif3a∆/∆;Hif1a∆/∆ (n=62). (C) Percentage of Ki67 positive cells per Ki67 positive cyst, Mean ± 
SEM, Kif3a∆/∆ (n=36), Kif3a∆/∆;Vhl∆/∆ (n=37), Kif3a∆/∆;Hif1a∆/∆ (n=36). 
 
Figure 5: Examples of the histological appearances of cystic lesions. Representative 
H&E stained sections of simple cysts (left) and atypical cysts (right) from Kif3a∆/∆ (A), 
Kif3a∆/∆;Vhl∆/∆ (B) and Kif3a∆/∆; Hif1a∆/∆ (C) mice 36 weeks after gene deletion was induced in 
adult mice. Scale bar =  20 µm. (D) anti-phospho Histone H3 (red) and DAPI (blue) staining 
of normal (left) and misoriented (right) anaphases. Scale bar = 10 µm. The local plane of the 
cystic epithelium was determined by drawing a line through the two adjacent nuclei and the 
anaphase plane was determined by drawing a line parallel to the midline of the dividing 
chromosomes to calculate the anaphase angle α. (E) Quantification of the angle α of 
anaphases in Kif3a∆/∆ (n=23), Kif3a∆/∆;Vhl∆/∆ (n=42) cystic epithelia. 
 
Supplementary Figure 1: Deletion of Vhl and Kif3a does not automatically initiate cyst 
formation. (A-C) Anti-HIF1α immunohistochemistry and (D-I) anti-Glut1 (green) and anti-
acetylated tubulin (red) co-staining of non-cystic (A-C,G-I) and cystic (D-F) regions of Kif3a∆/∆ 
(A,D,G), Kif3a∆/∆;Vhl∆/∆ (B,E,H) and Kif3a∆/∆;Hif1a∆/∆ (C,F,I) kidneys harvested 36 weeks after 
tamoxifen feeding. Scale bars = 50 µm (A-C) and 20 µm (D-I). In H the cells in the bottom 
half of the tubule show strong staining for Glut-1, indicating Vhl deletion, and lack primary 
cilia, indicating deletion of Kif3a, while the cells in the top half of the tubule do not stain for 
Glut-1 but do display primary cilia. 
 
Supplementary Figure 2: Cysts arise from multiple nephron segments. Examples of 
cysts that stain positively for the following tubular segment markers: (A) Tamm-Horsfall 
protein (THP, thick ascending loop of Henle), (B) sodium-chloride symporter (NCC, distal 
convoluted tubule), (C) sodium/phosphate cotransporter (NaPi, proximal tubule), (D) ATPase 
V1B1 subunit (ATPV1B1, distal tubule and collecting duct), (E) Aquaporin2 (Aqp2, collecting 
duct). (F) A cyst originating from the epithelium at the urinary pole of the glomerulus. Scale 
bars = 20 µm. 
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Supplementary Figure 3: Kidney parameters. (A) Two kidney volume (measured from 
µCT data) to bodyweight (2KV/BW) ratio and (B) two kidneyweight to body weight ratio 
(2KW/BW), Mean ± SEM, Kif3afl/fl (n=8), Kif3a∆/∆ (n=7), Kif3afl/fl;Vhlfl/fl (n=8), Kif3a∆/∆;Vhl∆/∆ 
(n=14), Kif3afl/fl;Hif1afl/fl (n=11), Kif3a∆/∆;Hif1a∆/∆ (n=9). (C) Correlation between µCT 
measurement of volume of kidneys with weight of kidneys. r2 reflects Spearman’s rank 
correlation coefficient with associated p-value. (D) Creatinine and (E) Urea levels were 
measured in blood plasma. Mean ± SEM, Kif3afl/fl (n=8), Kif3a∆/∆ (n=6), Kif3afl/fl;Vhlfl/fl (n=6), 
Kif3a∆/∆;Vhl∆/∆ (n=9), Kif3afl/fl;Hif1afl/fl (n=11), Kif3a∆/∆;Hif1a∆/∆ (n=9). Student’s unpaired T-test 
was performed and no significant differences were observed. 
 
Supplementary Figure 4: Repeated µCT imaging does not influence the cystic 
phenotype. Representative µCT images and H&E stained sections of (A) Kif3a∆/∆;Hif1a∆/∆ 
(n=4) and (B) Kif3a∆/∆;Vhl∆/∆ (n=10) mice 36 weeks after tamoxifen feeding. These mice were 
not subjected to monthly imaging and developed cysts similarly to mice that were repeatedly 
imaged. 
 
Supplementary Figure 5: Longitudinal imaging of cyst formation following gene 
deletion in P2 animals. Representative µCT images of (A) wild type, (B) Kif3a∆/∆, (C) 
Kif3a∆/∆;Vhl∆/∆, (D) Kif3a∆/∆; Hif1a∆/∆ and (E) Vhl∆/∆ mice taken at 8, 16, 28 and 36 weeks after 
gene deletion at P2 and corresponding histological section of one kidney (36 weeks) from 
each of the imaged mice. Mice were scored visually as having a moderate or severe cystic 
phenotype and the number of animals of each genotype with each score is shown. Scale bar 
in H&E images = 1 mm. 
 
Supplementary Figure 6: Verification of functional consequences of gene deletion in 
P2 animals. Representative H&E, anti-Hif1α and anti-acetylated tubulin staining of Kif3a∆/∆, 
Kif3a∆/∆;Vhl∆/∆, Kif3a∆/∆; Hif1a∆/∆ and Vhl∆/∆ kidneys. Scale bars = 20 µM. 
 
Supplementary Figure 7: Examples of the histological appearances of cystic lesions in 
P2 animals. Representative H&E stained sections of simple cysts (left) and atypical cysts 
(right) from Kif3a∆/∆ (A), Kif3a∆/∆;Vhl∆/∆ (B) and Kif3a∆/∆; Hif1a∆/∆ (C) mice 36 weeks after gene 
deletion was induced in P2 mice. Scale bar = 20 µm.  
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Name Sequence 5’-3’  Application 
Hif1a fwd GGA GCT ATC TCT CTA GAC C Genotyping / qPCR 
Hif1a rev GCA GTT AAG AGC ACT AGT TG Genotyping / qPCR 
Hif1a fl fwd TGG GGA TGA AAA CAT CTG CT qPCR 
Hif1a fl rev GTT GGG GCA GTA CTG GAA AG qPCR 
Kif3a P1 AGG GCA GAC GGA AGG GTG G Genotyping / qPCR 
Kif3a P2 GGC AGA TGG ATC TCT GTG AGT TTG Genotyping / qPCR 
Kif3a rec fwd GCA GAC GGA AGG GTG GTT TA qPCR 
Kif3a rec rev CTG CAA GAGGGT GGA AAG GA qPCR 
Ksp1.3-Cre fwd AGG TTC GTG CAC TCA TGG A Genotyping 
Ksp1.3-Cre rev TCG ACC AGT TTA GTT ACC C Genotyping 
rpS6 promoter rev AGT CAC TTC CGC CGG CTG TTC qPCR 
rpS6 promoter fwd GCG TCA CGA AAA AGA GGC CCG A qPCR 
Vhl fwd GGA GTA GGA TAA GTC AGC TG Genotyping  
Vhl rev GTA CAC CTG AGA GCG GCT TC Genotyping  
Vhl fwd1 CTG GTA CCC ACG AAA CTG TC qPCR 
Vhl fwd2 CTA GGC ACC GAG CTT AGA GGT TTG CG qPCR 
Vhl rev CTG ACT TCCACT GAT GCT TGT CAC AG qPCR 
Table S1: Primer sequences. 
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3.2  Additional animal studies performed 
In addition to the data given in the manuscript we further analyzed the P2 animals. 
Representative coronal µCT images and 3D reconstructions at 36 weeks after treatment are 
shown for Kif3a∆/∆, Kif3a∆/∆;Vhl∆/∆, Kif3a∆/∆;Hif1a∆/∆ and Vhl∆/∆ animals (Figure 3.2.1 A). We 
determined blood plasma creatinine (Figure 3.2.1 B) and Urea (Figure 3.2.1 C) levels of 
these animals. No significant differences between ∆/∆ genotypes and/or controls were 
observed (Figure 3.2.1 B+C). These results are similar to the data obtained from the adult 
animals. In the P2 animals we did not observe such severe polycystic kidney phenotypes 
probably due to the low dose of tamoxifen that we administered to the nursing dam. The 
variability between the litters is probably responsible for the great variances we measured for 
creatinine levels (Figure 3.21. B). Nevertheless, this data further supports the idea that µCT 
imaging is a suitable tool to detect and follow cyst formation in vivo and appears to be more 
sensitive than analysis of blood plasma creatinine and urea levels. 
 
Figure 3.2.1: Cyst analysis of gene deletion in P2 animals. µCT images at 36 weeks after treatment and 3D reconstructions of 
Kif3a∆/∆, Kif3a∆/∆;Vhl∆/∆, Kif3a∆/∆;Hif1a∆/∆ and Vhl∆/∆ animals (A) with kidneys (yellow) and cysts (red). Blood plasma levels of creatinine 
(B) and Urea (C) were measured 36 weeks after treatment.  
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3.3 Influence of Kif3a and Vhl co-deletion on proliferation, ATP levels 
and Glucose metabolism 
Having established that kidney specific co-deletion of Kif3a and Vhl leads to increased cystic 
burden in vivo we conducted a series of experiments to investigate potential underlying 
molecular mechanisms using culture of primary mouse embryo fibroblasts (pMEFs) and 
primary kidney epithelial cells (pKECs). Based on the fact that deletion of VHL leads to the 
accumulation of HIF1α which is able to mediate the Warburg effect in ccRCC and that 
recently the primary cilium was linked to the regulation of energy metabolism through 
mTORC1 (209-211), we investigated if the basic energy metabolism (ATP and Glucose) was 
changed upon loss of Vhl and/or Kif3a. We further speculated that possible deregulation of 
these metabolites may cause proliferative differences. 
pMEFs derived from E13.5 embryos from Kif3afl/fl, Kif3afl/fl;Vhlfl/fl, Vhlfl/fl and wild type 
(wt) animals were cultured under 5% O2 cell culture conditions. Gene deletion was mediated 
by adenoviral delivery of Cre recombinase (or GFP as control) and the knockout efficiency 
was confirmed by western blot (Figure 3.3.1 A). Intracellular ATP levels were measured with 
the CellTiter-Glo Luminescent Cell Viability Assay but no difference was observed either 
between Cre-treated (∆/∆) and GFP control cells of the same genotype nor between 
genotypes (Figure 3.3.1 B left). Glucose utilization was measured by determining the levels 
of lactate and glucose in the medium of ∆/∆ and control cells. Only Kif3a∆/∆;Vhl∆/∆ cells 
exhibited increased levels of lactate in the medium (Figure 3.3.1 B middle). However, 
surprisingly these cells also used less glucose which is reflected in the higher amount of 
glucose in the medium after a 48 hour culture period (Figure 3.3.1 B right). Deletion of Kif3a 
and Vhl together or alone did not result in increased proliferation in pMEFs rather a slight 
reduction in all ∆/∆ pMEFs was observed (Figure 3.3.1 C). The results that we obtained from 
the analysis of our pMEFs are consistent with the data observed in our in vivo model and 
clearly show that the pMEFs are neither immortalized nor transformed. 
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Figure 3.3.1: Effects of Kif3a and Vhl deletion on basic metabolism and proliferation in pMEFs. (A) Representative western blot of 
Kif3a, Vhl and actin of Cre-treated and GFP control protein lysates from wt, Vhlfl/fl, Kif3afl/fl and Kif3afl/flVhlfl/fl pMEFs. (B) Relative levels of 
cellular ATP (left), lactate (middle) and glucose (right) in the medium of treated and control pMEFs. N=3. (C) Proliferation curves of 
pMEFs, representative graphs of three independent experiments given. Labels on the middle panel of B need to have the fl/fl in 
superscript and the Vhlfl/fl is missing from the Kif Vhl genotype (last label, middle graph). 
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While pMEFs are a cell type that is easy to work with experimentally, we sought to 
better reproduce the animal models by isolating pKECs from the various fl/fl mice and 
performing proliferation assays and basic metabolism assays following administration of 
adenoviruses expressing GFP or Cre. Culturing of pKECs was achieved by digestion of 4-6 
week old mouse kidneys and culturing in defined medium containing growth factors that 
allow epithelial cell proliferation but prevent stromal cell proliferation. This culture system was 
validated by showing that pKECs express an epithelial cell marker (E-Cadherin) and tubular 
markers (NaPi and NKCC2) (Figure 3.3.2 A) and form an epithelial layer in 5% O2 standard 
cell culture (Figure 3.3.2 B). However, after 2-3 weeks in culture, pKECs lose their epithelial 
properties and adapt the shape of mesenchymal cells (Figure 3.3.2 C). 
Figure 3.3.2: Properties of pKECs in standard cell culture. (A) western blot of an epithelial marker (E-Cadherin), a proximal tubule 
marker (NaPi) and a collecting duct marker (NKCC2), β-actin was used as loading control. Brightfield microscopy of pKECs after 12 (B) 
and 21 (C) days in cell culture. 
 
We confirmed the gene knockout on protein level by western blotting on pKECs used 
for the experiments and the targeted genes were completely abrogated as intended (Figure 
3.3.3 A). Cre treatment led to a small decrease of intracellular ATP levels in all genotypes 
(Figure 3.3.3 B top left). A slight decrease in uptake of 2-deoxyglucose (2-DOG), a marker for 
glucose uptake, was measured but was only significant between Vhl∆/∆ and Vhlfl/fl cells 
(Figure 3.3.3 B top right). 2-DOG is transported with the same kinetics as glucose but once 
inside the cell it cannot be phosphorylated and eventually completely inhibits glucose 
metabolism. Therefore, 2-DOG uptake is actually not the best way to study glucose 
metabolism. No significant changes in glucose utilization and lactate production were 
measured in the conditioned medium of pKECs (Figure 3.3.3 B lower panels). We also 
performed short term growth curves for all the genotypes since pKECs do not permit 
repeated splitting and long culture conditions. Cells were seeded and after initial cell growth 
gene deletion was facilitated by adeno-Cre or adeno-GFP as control. Cells were fixed on five 
consecutive days and protein content was determined by SRB staining. No difference 
between ∆/∆ and control cells was observed during this period (Figure 3.3.3 C). In fact, the 
overall proliferation of the pKECs during cell culture is very low as can be seen by the 
relative proliferation depicted in Figure 3.3.3 C. The relative strong increase in Kif3fl/fl pKECs 
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might also be due to the fact that the number of cells per well is in part dependent on the 
amount of cells which initially attach after seeding. We concluded that the low rates of 
proliferation and tendency of the cells to undergo dedifferentiation in culture mean that this 
assay is not a reliable or meaningful one. Nonetheless, it is clear that the Kif3a/Vhl double 
mutant renal epithelial cells are neither immortalized nor transformed, consistent with the 
data from in vivo gene deletion. 
 
Figure 3.3.3: Effects of Kif3a and Vhl deletion on basic metabolism and proliferation in pKECs. (A) Representative western blot of 
Kif3a, Vhl and actin of Cre-treated and GFP control protein lysates from wt, Vhlfl/fl, Kif3afl/fl and Kif3afl/flVhlfl/fl pKECs. (B) Relative levels of 
cellular ATP (left), 2-DOG uptake (middle left) lactate (middle) and glucose (right) in the medium of treated and control pKECs. N=4. (C) 
SRB curves of pKECs, representative graphs of three independent experiments given. 
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3.4 Primary kidney epithelial cells form polarized acini in a matrigel-
based 3D cell culture assay 
Since growth of cells on standard cell culture plastic does not reflect the epithelial cell-cell 
interactions that occur in the context of renal tubules we sought to study the role of Kif3a and 
Vhl in cyst formation in vitro by establishing a new 3D renal epithelial cell culture model. To 
do so we used mouse primary kidney epithelial cells (pKECs) for two reasons. First, we 
wanted to study the deletion of Kif3a and/or Vhl in otherwise unaltered cells, which is not 
possible if cultured immortalized cell lines were used. Secondly, the use of pKECs gave us 
the possibility to use our previously generated mouse strains to delete the gene 
combinations we want. We tested several different protocols. Initially, we started our 3D cell 
cultures with a protocol (202) that uses a murine cortical collecting duct (mCCD) cell line in a 
3D model. Figure 3.4.1 A+B show the tube formation capacity of the mCCD cells whereas 
our pKECs did not exhibit this function in the kind of 3D structure (Figure 3.4.1 C+D). This 
may be due to the fact that we used freshly isolated cells and not an established clone of a 
cell line. 
 
Figure 3.4.1: Tube formation capacity of mCCD and pkECS. mCCD cells after 4 days (A) and 7 days (B) in 3D culture show tube 
formation. pKECs after 4 days (C) and 7 days (D) do not exhibit this feature. Scale bars are 200µm. Pictures A+B taken from Montesano 
et al. (202). 
Results 
80 
 
 To continue with the 3D cell culture we experimented with different published protocols 
for 3D cell culture systems and used renal tubule segments or isolated pKECs in these 
systems (205, 212, 213). Figure 3.4.2 shows the comparison of the protocols. The protocol 
from Lee et al. published in Nature Protocols in combination with our pKECs leads to the 
formation of acini-like structures as shown in the literature for epithelial cells (197-199). 
Unfortunately, the addition of HGF did not lead to the outgrowth of cells from the acini-like 
structures or enhanced tube formation in any of the tested conditions (Figure 3.4.2 lower 
panel).  
 
Figure 3.4.2: Overview of different 3D cell culture protocols. Scale bar 20µm 
With this protocol our pKECs were able to form acini-like structures in the 3D assay 
and a clear lumen is visible in higher magnification brightfield pictures (Figure 3.4.3A+B). To 
confirm that our acini-like structures truly derive from epithelial cells we performed 
immunofluorescence stainings. We could detect that all cells forming the 3D structure stain 
positively for E-Cadherin, a marker of epithelial cells (Figure 3.4.4). Co-staining for ß-Catenin 
was used as an alternative way to visualize the cell border between single cells (figure 3.4.4 
A) and validated the epithelial nature of the cells. In addition, we observed that some of the 
cells comprising an acinus bind either LTA or DBA, marker for proximal tubule or collecting 
duct, respectively (Figure 3.4.4 A). Taken together these results indicate that our acini are 
derived from epithelial cells and they maintain tubule segment specific features in the 3D 
system. Secondly, it also shows that acini are not always formed by a single cell but may 
originate from two or more aggregated cells from different nephron segments. Furthermore, 
we investigated if the cells in our acini-like structures maintain their polarization which is 
usually lost in standard 2D cell culture. For this purpose we stained for acetylated tubulin, a 
protein highly abundant in the primary cilium of polarized renal epithelial cells. The primary 
cilium is only visible in non-proliferating cells and cilia of cells in an epithelial layer all point to 
same direction, into the lumen of the renal tubule. Polarization towards the lumen of the 
structure was observed in our pKECs 3D cell culture system (Figure 3.4.4 B).  
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 Having validated that this culture system allows maintenance of epithelial 
characteristics of primary cells in culture, we next sought to study the effect of loss of Vhl and 
Kif3a.  We transduced acini with adenoviral vectors to induce gene deletion. We used a 
relatively low titer of adenovirus to prevent toxic side effects which were observed if high titer 
adenoviral vectors were used in standard cell culture. The low titer resulted mainly in partial 
and sometimes in complete transduction of acini (Figure 3.4.3 A). Unfortunately, the protein 
amount we obtained from the 3D cell culture was too low to confirm the knockout by 
immunoblot. Recombination of the Kif3a gene locus results in loss of the primary cilium. We 
observed that some of the cells in Kif3a∆/∆;Vhl∆/∆ acini indeed did not form the primary cilium 
(Figure 3.4.4 C). One reason that we did not observe acini in which all cells lacked the 
primary cilium may be due to the low adenoviral titer we used in our experiments. Another 
reason may be the time point of Kif3a inactivation. A recent publication showed that 
reabsorption of the primary cilium may take up to 15 days after deletion of Kif3a (214). 
Unfortunately, acini without deletion of Kif3a also contained cells that lacked a primary cilium 
(Figure 3.4.4 C) indicating that some of the cells in the acini are still proliferating. This made 
it impossible for us to distinguish the treated from the untreated 3D cultures using the 
presence or absence of the primary cilium as a marker. Nonetheless, we assumed that gene 
deletion had occurred successfully and screened multiple acini.  We observed no obvious 
morphological changes in Kif3a∆/∆;Vhl∆/∆ acini compared to Kif3afl/fl;Vhlfl/fl controls. We 
measured the diameter of acini formed by Kif3a∆/∆;Vhl∆/∆ and Kif3afl/fl;Vhlfl/fl pKECs but saw no 
significant differences (Figure 3.4.3 C). The partial gene deletion may induce very subtle 
changes, which we could not measure with our experimental system. We conclude that 
additional mutations may be necessary to overcome the repressive environment exerted by 
epithelial cell-cell contact within the acini or that this cell culture system does not accurately 
reproduce factors that are necessary in vivo for cyst formation, such as urinary flow, growth 
factor signalling or interactions with basement membranes or stromal cells. 
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Figure 3.4.3: Acini formation of pKECs. (A) BF and immunofluorescence images of pKECs acini trandsduced with Adeno-Cre-GFP or 
Adeno-eGFP 3 days after seeding. (B) Bright field microscopy of Kif3a∆/∆;Vhl∆/∆ pKECs acini. (C) Diameters of Kif3afl/fl;Vhlfl/fl and 
Kif3a∆/∆;Vhl∆/∆ pKECs are 57.5±24.8 and 66.1±29.6, respectively; N=16. Pictures are taken 10 days after seeding. All bars represent 
20µm. 
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Figure 3.4.4: pKEC acini exhibit a polarized orientation epithelial origin. (A) Co-staining of DBA (collecting duct) with ß-Catenin (cell 
junction) or LTA (proximal tubues) with E-Cadherin (epithelial marker), bars equal 30µm. (B) anti-acetylated Tubulin staining (red) and 
anti-E-Cadherin (green) in pKECs acini, bars equal 20µm. (C) anti-acetylated Tubulin staining (red) and anti-E-Cadherin (green) in 
Kif3afl/fl;Vhlfl/fl  acini treated with Cre (left) or GFP (right), bars equal 30µm. Pictures in A+C were taken with an SP5 confocal microscope. 
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4 Discussion 
Despite intensive research, the molecular and cellular mechanisms underlying the generation 
of ccRCC remain unknown and no autochthonous mouse model for this disease has been 
developed yet. The results presented in this study complement previous studies and 
generate ideas for future experiments. A proposed model of ccRCC initiation in which loss of 
the microtubule stabilizing function of pVHL in combination with altered PI3K and ERK 
signaling causing failure to maintain the primary cilium suggested that loss of this organelle is 
the trigger for pre-neopastic cyst formation in VHL patients can now be further adjusted (20, 
51, 66). We observed a drastic increase in the frequency of cyst initiation, enhanced cyst 
progression and a shortened latency if Vhl was deleted together with Kif3a compared to 
Kif3a deletion alone. This serves as evidence that loss of the primary cilium is a secondary 
event in VHL mutant cells that in turn cooperates with other cellular changes which arise due 
to loss of pVHL function and that all these effects together induce cyst formation. Multiple 
mechanisms may underlie this cooperation due to the diversity of molecular and cellular 
processes which are regulated by pVHL and by the primary cilium itself (215, 216). 
Our mouse model of combined Vhl and Kif3a deletion shows a high frequency of cyst 
formation in 100% of mice at nine months after Tamoxifen treatment. This is a huge increase 
compared to the small fraction (~20%) of older (>1year) mice that develop cysts if Vhl is 
deleted in proximal tubular epithelial cells using the Pepck-Cre transgene (19). Since the 
effect of Vhl deletion alone under the control of the Pepck-promoter could be rescued by co-
deletion of Arnt, encoding HIF1β, but not by co-deletion of Hif1a, it is possible that cyst 
formation in our Kif3a/Vhl mouse model is promoted by combined activation of HIF1α and 
HIF2α (19). A more general role for HIF1α in cyst formation was recently proposed (43, 217). 
However, in our study we found no HIF1α stabilization or increase in expression of the HIF1α 
induced protein Glut-1 in cysts in Kif3a mutant mice. There were no phenotypic 
consequences of Hif1a deletion on loss of Kif3a-induced cyst formation. Since our Kif3a 
deletion model results only in a mild cystic phenotype it may be that HIF1α stabilization is 
only limited to more severe polycystic kidneys. On the other hand, altered signaling pathways 
induced by PKD1/PKD2 mutations in autosomal dominant kidney disease may contribute to 
HIF1α stabilization in cysts, for example constitutive mTOR activation causes enhanced 
translation of HIF1α in a way that cannot be phenocopied by loss of the primary cilium (82, 
209, 218-220). To test the effect of HIF1α in a more severe mouse model we would propose 
the deletion of Hif1a in an ADPKD model or study the effect of developmental Hif1a/Kif3a 
deletion which results in a stronger cystic phenotype than observed in adult mice. 
Another conclusion that can be drawn from our in vivo studies is that Vhl-deficient 
cystic lesions can persist for at least nine months in mice without neoplastic progression. 
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This suggests that additional mutations are necessary to result in malignant transformation. 
Nevertheless, we observed a 3-4 fold increase in the frequency of atypical cyst formation in 
Kif3a∆/∆;Vhl∆/∆ mice compared to Kif3a∆/∆ and Kif3a∆/∆;Hif1a∆/∆ mice. These cysts displayed a 
multilayered epithelial growth projecting into the lumen of cystic lesion. Since simple cysts 
are believed to progress into atypical cysts and ultimately into ccRCC in the cyst-dependent 
ccRCC progression model (Figure 1.3) (63-66), we believe that Kif3a∆/∆;Vhl∆/∆ mice 
accurately mimic ccRCC precursor lesions. While Kif3a∆/∆;Vhl∆/∆ mice exhibited numerous 
simple cysts, the frequency and extent of atypical growth in this model is much less than that 
seen in Vhl/Trp53 mutant mice. The combined deletion of Vhl and Trp53 resulted a much 
lower rate of cyst formation but frequent appearance of atypical cysts characterized by 
extensive epithelial proliferation into the lumen of cystic lesions and solid neoplasms that 
apparently filled the lumen (24). This data leads to the conclusion that loss of the primary 
cilium in combination with loss of pVHL functions as an initial cause for the onset of cyst 
formation and for the transition to disorganized epithelial proliferation but that it is not 
sufficient for persistent neoplastic growth. The deletion of a tumour suppressor like Trp53, Rb 
or Cdkn2a in Kif3a∆/∆;Vhl∆/∆ mice might enhance the transition of the frequent simple and the 
rare atypical cystic lesions to the next stage of ccRCC progression model. In this context we 
have recently generated mice allowing inducible renal epithelial-specific triple deletion of 
Kif3a/Vhl/Trp53. These mice will be analysed in the coming months. 
One cellular process that may explain the observed phenotypes may be the 
dysregulation of a process called planar cell polarity (PCP) which ensures the correct 
orientation of the mitotic spindle and correct planar cell division. Normally, renal epithelial cell 
division occurs along the length axis of the tubule to ensure lengthening during development 
or repair after kidney injury. It was also shown that the orientation of the mitotic spindle was 
distorted in rodent PKD models (138). Disturbance of the PCP pathway and therefore 
misoriented mitotic spindle formation might lead to the transition of normal tubules to cystic 
enlargements. Multiple studies have linked the loss of the primary cilium to misorientation of 
cell division that precedes cyst formation (reviewd in (221)). Rapid and dramatic cyst 
formation is seen upon perinatal loss of the primary cilium but is not observed when the 
primary cilium is deleted in quiescent renal epithelial cells of adult animals, rather slow onset 
cyst formation results (94, 141). Kidney damage-induced proliferation leads to rapid cyst 
formation in adult animals that have genetic ciliary defects, implying a synergistic interaction 
between proliferation and misoriented mitotic spindle formation. Interestingly, pVHL regulates 
the stability of the astral microtubule network that links the mitotic spindle to the cell surface, 
thereby controlling the correct orientation of cell division (144). Recently, a mouse model of 
Vhl deletion that was subjected to ischemic damage causing cellular proliferation showed 
misoriented mitotic spindle formation and these mice developed microcysts (145). Taken 
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together, this data leads to the plausible conclusion that the disturbance of two independent 
pathways that ensure cell division in the correct plane may enhance the rate of misorented 
cell division which could result in a more frequent tubule expansion and cyst initiation (Figure 
4.1 A). The transition from simple cysts into atypical cysts may be based on the same 
mechanism. The expansion of a simple cyst requires that cells divide within the plane of the 
cystic epithelium. We propose that the transition to multilayered/atypical cysts may occur if 
cell divisions occur perpendicularly to the plane of the epithelial cells that line the cysts, 
resulting in daughter cells that are growing on top of the existing cystic epithelium (Figure 4.1 
B). We found that approximately one third of anaphases of Kif3a∆/∆;Vhl∆/∆ mice show an 
altered mitotic spindle orientation compared to roughly one eighth of anaphases in Kif3a∆/∆ 
animals. This result supports our hypothesis (Figure 4.1) that one possible mechanism 
contributing to the cooperative effect from loss of Vhl and loss of the primary cilium is based 
upon loss of correct mitotic spindle orientation. It is noteworthy that the frequency of 
misoriented anaphases is higher than the incidence of atypical cyst formation. We speculate 
that not all cell divisions that occur perpendicularly to the plane of the cyst result in daughter 
cells attaching to the cyst wall as these cells would lack contacts with the extracellular matrix 
of the basement membrane. It is possible that some or many of the recently divided cells 
may detach from the cyst wall and enter the cystic space where they may undergo apoptosis. 
It is also possible that additional mutations need to occur that further increase proliferation 
and enable neoplastic growth are required to induce renal cancers.  
 
 
Figure 4.1: Influence of mitotic spindle orientation on cyst initiation and progression. (A) Mitotic spindle orientation 
along the length axis of a renal tubule leads to lengthening during development and after kidney injury. Orientation of the mitotic spindle 
perpendicular to the tubule axis may result in tubule enlargement, which initiates simple cyst formation. (B) Continuous division along the 
plane of the cyst wall leads to enlargement of simple cysts whereas division perpendicular to the axis of the cyst wall might initiate 
multilayered and atypical cystic phenotypes. 
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In vitro experiments were performed to investigate molecular and cellular changes that were 
induced through the co-deletion of Kif3a and Vhl. We used pMEFs and pKECs derived from 
our mouse lines. We investigated the effect of Kif3a and Vhl co-deletion on proliferation and 
metabolic changes. In pMEFs we measured intracellular ATP levels, glucose utilization and 
lactate production. These metabolic properties are frequently altered in malignant 
transformed cells and contribute to the Warburg effect. We could not detect any significant 
differences based on these assays indicating that the pMEFs did not undergo malignant 
transformation. Proliferation curves were performed to assess differences in proliferation 
between all genotypes. The proliferation of ∆/∆ cells was slightly but not significantly 
decreased compared to their respective control cells concluding that loss of Kif3a and Vhl 
does not result in enhanced proliferation rates. We reasoned that pKECs might be better 
suited to reproduce the animal models and therefore performed proliferation assays and 
basic metabolism assays after treatment with adeno-Cre-GFP or adeno-eGFP as control. 
While pMEFs are easy to handle pKECs are more difficult to work with experimentally 
because they have a low proliferation rate, tend to undergo dedifferentiation and do not 
permit passaging. To test the proliferation rate of pKECs we performed a SRB assay on five 
consecutive days but the proliferation rate was in general low and no difference between ∆/∆ 
and control cells was observed. The analysis of basic metabolism also did not show a 
difference in intracellular ATP levels, glucose utilization, lactate production and 2-DOG 
uptake. Taken together our in vitro data is consistent with the animal models and clearly 
shows that loss of the primary cilium and loss of Vhl is not sufficient to induce either 
immortalization or malignant transformation. 
 
We developed a non-invasive technique that allows quantitative longitudinal monitoring of 
cyst progression in the same living animal based on computed tomography (µCT). µCT 
imaging is usually deployed for the analysis of fixed tissues ex vivo. In 2008, the first 
description of µCT imaging of mice kidney in living animals was reported (191). So far renal 
cysts were only analyzed ex vivo in a rat model (222). Here we described for the first time 
µCT in vivo imaging of mouse renal cysts. We performed µCT scans of anaesthetized 
animals. Since the µCT is based on X-ray images we used iodine containing contrast agent 
(Visipaque®) to be able to visualize the kidney. Intraveneous administration of the contrast 
agent leads to renal filtration and accumulation of the contrast agent in the kidney tubules but 
is not concentrated in the cystic regions due to either impaired filtration or concentration. Our 
µCT approach generated similar results to CT imaging of patients with cystic kidney disease. 
Our data shows that this technique is suitable to visualize and follow cyst formation over time 
in the same animals. We believe that µCT imaging to monitor cyst formation is superior to 
measurements of standard kidney function parameters like blood urea and creatinine levels 
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as this imaging technique is able to detect cystic lesions in transgenic animals that do not 
differ in blood urea and creatinine levels from wild type animals. The analysis of kidney 
parameters showed that only those transgenic animals with very severe cystic phenotypes 
displayed increases in blood urea nitrogen and creatine, whereas µCT imaging was able to 
quantitatively assess renal cysts also in transgenic animals with a very few cystic lesions. 
The data we obtained from µCT imaging was confirmed by histological analysis, further 
supporting the evidence that µCT imaging is more sensitive than analysis of blood urea and 
creatinine levels. In addition, our technique might help to reduce the number of animals 
needed to perform such experiments since one can conduct multiple quantitative 
measurements within the same animal. We believe that this technique might be of great use 
especially for clinical researchers testing treatment options for cystic diseases. It is now 
possible to determine the cystic volume of the exact same animal before, during and after 
treatment. We also analyzed transgenic animals only at nine months after tamoxifen 
treatment to rule out any side effects of repeated anaesthesia and Visipaque® administration 
and indeed we observed the same cystic phenotype. Our research on µCT in vivo imaging 
may generally prove to be beneficial for all future studies that aim to investigate polycystic 
kidney disease in rodent.  
 
To study molecular and cellular processes of cyst initiation/progression ex vivo we developed 
a Matrigel®-based 3D culture system. Several kidney-derived cell lines were available for 3D 
systems (198, 200-202) but since we wanted to study the process of cyst initiation of 
physiologically normal kidney epithelial cells we utilized pKECs in our 3D culture system. The 
use of pKECs also provides the advantage of being able to induce genetic changes through 
viral delivery of Cre in pKECs from Kif3afl/fl, Kif3afl/fl;Vhlfl/fl and Vhlfl/fl mice. The modification of 
a recent 3D culture protocol (Lee et al Nature) allowed the growth of polarized pKECs as 
acini in a Matrigel®-based 3D culture system. These acini resemble the 3D structures that 
arise from the 3D culturing of other epithelioid cell lines (197-199). Furthermore, marker 
stainings showed that the pKECs are indeed derived from renal epithelial tubule cells 
therefore allowing researchers in general to take advantage of all available genetically 
modified mouse strains for renal epithelial 3D systems. Cre-mediated recombination can be 
performed at different time points during pKECs isolation and most likely with inducible Cre 
lines if the promoter is active in the respective cell type. Our data shows that we can 
generate polarized acini with a primary cilium facing the lumen resembling the in vivo 
situation of renal epithelial tubule cells and hence may be used to study cyst initiation ex 
vivo. Unfortunately, we could not observe cyst formation in Kif3a∆/∆;Vhl∆/∆ or Kif3a∆/∆ acini. 
This is probably due to the low concentration of Adeno-Cre-GFP we used because we 
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observed a strong Adeno-Cre-GFP toxicity on 2D cultured pKECs. The use of lentiviral 
vectors expressing Cre may help to overcome this problem. Another way would be the use of 
tamoxifen-induced Cre translocation with the KspCreERT2 transgenic lines. Taken together, 
this new cell culture model system allows the formation of polarized acini resembling the in 
vivo orientation of renal epithelial cells but deletion of Kif3a and Vhl was so far not sufficient 
to overcome the suppressive environment of the 3D structure on uncontrolled proliferation 
and cyst formation. In an ex vivo screening approach to identify genetic cooperation partners 
that may promote neoplastic transformation of cysts, it would be interesting in future 
experiments to utilize this 3D culture system with pKECs derived from Kif3a/Vhl floxed 
animals and introduce additional genetic changes that are found in human ccRCCs. Those 
combinations that allow transformation may permit proliferation of cells into the lumen of acini 
or outgrowths of acini to form solid or invasive structures. Candidate genes could then 
potentially be considered to introduce into the inducible Kif3a/Vhl deletion mouse model to 
attempt to generate a model of cystic ccRCC. 
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